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Abstract  
 
Background: 
Therapeutic hypothermia following perinatal hypoxia-ischaemia improves 
survival and neurological functioning at 18 months of age. Precise brain 
temperature control commenced shortly after birth may improve the beneficial 
effects. 
 
Aims:  
The aim of this thesis was (i) to clarify associations of regional brain 
temperatures with the body weight, ambient temperature, cerebral perfusion and 
oxygen metabolism under normothermia and induced hypothermia; and (ii) to 
develop safe and reliable cooling device for pre-hospital cooling. 
 
Methods: 
1. Regional brain temperatures were monitored in 14 anaesthetised newborn 
piglets with normothermia, whole body cooling and selective head cooling. 
2. The rectal temperature (Trectal), non-invasive brain temperatures (zero-heat 
flux method), relative superior vena-cava (rSVC) flow (rSVC flow; 
echocardiography) to the brain weight, and the cerebral metabolic rate of 
oxygen relative to rSVC flow (CMRO2 index; measured using near-infrared 
spectroscopy), were obtained in 32 newborn infants.  
3. Eleven anaesthetised newborn piglets were cooled to 33-34oC 2-26 h after 
hypoxia-ischaemia using either water bottles or phase changing material 
(PCM), which works as a heat buffer at 32oC.  
 
Results:  
1. In the piglet model, brain temperatures were positively correlated with the 
body weight under normothermia, whole body cooling and selective head 
cooling, the influence of which was prominent under selective head cooling. 
2. In the normothermic newborn infant, rSVC flow and CMRO2 index were 
positively coupled between each other. A greater rSVC flow was associated 
with higher superficial brain temperatures; brain temperatures were 
independent of the CMRO2 index. A cooler ambient temperature was 
associated with a greater temperature gradient between the scalp surface 
and the body core. 
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3. In the piglet model, therapeutic hypothermia was induced and maintained 
with both water bottles and PCM; the latter provided more stable cooling 
within the target range.  
 
Conclusions: 
Brain cooling was more efficient with lower body weight due to greater head 
surface area to volume ratios; body-size adjustment may be required to 
accomplish consistent regional temperatures. In healthy newborn infants under 
thermo-neutral temperature, cerebral perfusion and ambient temperature, but 
not cerebral metabolism, were significantly associated with brain temperatures. 
PCM cooling provided stable body temperatures, which may substitute for 
electronic cooling devices during transportation.  
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1.1  Impact of perinatal hypoxia-ischaemia 
1.1.1 Global impact of perinatal hypoxia-ischaemia and neonatal 
encephalopathy 
Acute neonatal encephalopathy following perinatal hypoxia–ischaemia is a major cause 
of neonatal death in developing countries, where approximately 23% of annual neonatal 
deaths worldwide are attributed to perinatal hypoxia–ischaemia (1).  
Perinatal hypoxia–ischaemia remains a common causative of neonatal death and 
permanent neurological deficit even in developed countries, where the incidence of 
moderate to severe neonatal encephalopathy is 1 to 2 per 1000 term births in the UK 
and other parts of the developed world (2, 3).  
 
Figure 1.1: Country variation in third-trimester stillbirth rates in 2008  
 
The rate of stillbirth in developing countries remain much higher compared to the rate in 
developed countries. 
From “Stillbirths: Where? When? Why? How to make the data count?” by Lawn JE, 
Blencowe H, Pattinson R, Cousens S, Kumar R, Ibiebele I, Gardosi J, Day LT, Stanton C; 
Lancet's Stillbirths Series steering committee. Lancet. 2011 Apr 23;377(9775):1448-63.   
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Figure 1.2: Stillbirths, early neonatal deaths and causatives 
 
Antepartum stillbirths, intrapartum stillbirths, and early neonatal deaths with fetal (A) or 
neonatal (B) causes and associated maternal conditions (C). Data based on 19,976 
stillbirths and 8562 neonatal deaths in South Africa, 2008–09. Data from Medical Research 
Council Maternal and Infant Health Care Strategies Research Unit.72  
From “Stillbirths: Where? When? Why? How to make the data count?” by Lawn JE, 
Blencowe H, Pattinson R, Cousens S, Kumar R, Ibiebele I, Gardosi J, Day LT, Stanton C; 
Lancet's Stillbirths Series steering committee. Lancet. 2011 Apr 23;377(9775):1448-63.  
Abbreviation: APH, antepartum haemorrhage.
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The outcome associated with neonatal encephalopathy varies according to the type, 
depth and duration of hypoxic-ischaemic events as well as the maturational state of the 
infant’s brain. Infants with mild neonatal encephalopathy generally recover well without 
apparent neurological impairments (4, 5). In contrast, subjects with moderate to severe 
neonatal encephalopathy are at significant risks for neonatal mortality or survival with 
serious neurodevelopmental impairments; it is this group of infants who benefit from 
neuroprotective treatments, with a reduction in the risk of death or disability and 
increased survival free of disability at 18-24 months (6-10). The favourable outcome at 
18-24 months is associated with favourable outcomes at 6-7 years (11, 12). 
 
1.1.2 Mechanism of cerebral injury following perinatal hypoxia-ischaemia 
Brain injury after transient hypoxia–ischaemia is an evolving process (13): severe 
hypoxia–ischaemia causes acute energy depletion to the cerebral tissue, leading to 
immediate cell death to a fraction of neuronal and glial cells. Successful resuscitation 
may help restore cerebral energy metabolism, however, reperfusion/reoxygenation may 
additionally precipitate complex biochemical events, which eventually lead to secondary 
energy failure evolving after 8-30 h of resuscitation (14), and some additional delayed 
neuronal death (15-19).  
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Figure 1.3: Acute hypoxia-ischaemia and evolution of secondary energy failure 
 
NTP (mainly adenosine triphosphate) relative to EPP with time in the piglet model of 
asphyxia encephalopathy. Following successful resuscitation, cerebral high energy 
phosphate transiently recovers to the normal level (latent phase), which is followed by 
SEF after 8-30 h.  
Abbreviation: HI, hypoxia-ischaemia. SEF, secondary energy failure. EPP, exchangeable 
high-energy phosphate. NTP, Nucleotide triphosphate. 
 
Experimental studies suggested that neuroprotective treatments are likely to be 
beneficial only when they are applied before the overt evolution of secondary energy 
failure (13). A study in a piglet model of neonatal hypoxia–ischaemia demonstrated that 
the greater the acute energy deficit, the sooner the evolution of secondary energy 
failure, highlighting the importance of early initiation of treatments for severely 
asphyxiated subjects (20). 
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1.2  Hypothermic neuroprotection for neonatal encephalopathy 
1.2.1 Mechanisms of hypothermic neuroprotection 
A range of neuroprotective treatments have been proposed by basic scientists, the 
number of which is still increasing every year (21, 22). However, no pharmacological 
treatment has thus far been confirmed to be clinically neuroprotective in the newborn 
infant, except for magnesium sulphate, which is administered antenatally in the preterm 
infant (23). In contrast, therapeutic hypothermia has demonstrated exceptional 
neuroprotective properties in both experimental and clinical settings.  
 
Figure 1.4: Injury cascade following perinatal hypoxia-ischaemia 
 
 
Diagram depicting the deleterious 
injury cascade following 
hypoxic-ischaemic stress. Even 
after successful resuscitation, 
cytotoxic neuronal injury persists 
resulting in acute necrosis and 
delayed apoptosis in the tissue. 
Hypothermia is known to 
ameliorate most of these 
degenerative reactions.  
 
Abbreviations: AIF, apoptosis inducing factor. Ca, calcium. Cas, caspase. Cyt C, 
cytochrome c. MPT, mitochondrial permeability transition. NAD, nicotinamide adenine 
dinucleotide. Ox Radicals, oxygen radicals. PARP, Poly （ADP-Ribose） Polymerase. 
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Unlike some pharmacological treatments targeting specific stages within the injury 
cascade, the neuroprotective effect of therapeutic hypothermia covers a wide range of 
deleterious reactions (24). Therapeutic hypothermia reduces the metabolic rate of the 
cerebral tissue by approximately 4–7% for 1°C temperature reduction (25-27), 
decreases the release of glutamate and other excitotoxic neurotransmitters (28, 29), 
attenuates the activity of N-methyl-D-aspartate receptors (30), reduces the production 
of nitric oxide and oxygen radicals (30-32) and contributes to decreasing intracranial 
pressure (33, 34). 
 
1.2.2 Neuroprotective effect of therapeutic hypothermia in preclinical 
models 
In preclinical models, mild to moderate therapeutic hypothermia (temperature 32-34oC) 
reduces secondary brain injury and improves behavioural outcome when applied 
immediately after transient hypoxia–ischaemia (35-37).  
There is also evidence to suggest that significant long-term neuroprotection occurs in 
experimental models even with a delay of 2-6 h between hypoxia–ischaemia and the 
commencement of cooling (38-43).  
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Figure 1.5: Neuronal loss following fetal ischaemia with or without selective head 
cooling 6-72 h after resuscitation 
 
 
 
 
 
 
 
 
Microscopic neuronal loss was assessed in different brain regions 5 days after ischemia. 
A significant overall reduction in neuronal loss was seen in fetuses treated with selective 
cerebral cooling (closed bars) compared with sham-cooled fetuses (open bars), except in 
the most severely affected field of the hippocampus, CA1/2.  
From “Neuroprotection with prolonged head cooling started before postischemic 
seizures in fetal sheep.” by Gunn AJ, Gunn TR, Gunning MI, Williams CE, Gluckman PD. 
Pediatrics. 1998 Nov;102(5):1098-106. 
Abbreviations: DG, dentate gyrus.CA1/2, hippocampus zone 1 and 2. 
 
 
1.2.3 Clinical trials of therapeutic hypothermia for neonatal 
encephalopathy 
Based on the accumulated preclinical evidence and the safety consideration by several 
clinical pilot studies, two large-scale randomised controlled trials of therapeutic 
hypothermia were carefully designed and conducted in infants with moderate to severe 
neonatal encephalopathy. These clinical studies, using selective head cooling or whole 
body cooling, demonstrated that mild to moderate therapeutic hypothermia was 
25 
 
associated with significant reduction in death or severe disability at 18 months of birth, 
except in subjects who showed the most severe pattern on the amplitude-integrated 
electroencephalogram (aEEG) and were cooled using selective head cooling (8, 9). 
Further large-scale trials of therapeutic hypothermia using similar patient selection and 
cooling criteria to the former trials consistently confirmed the neuroprotective effect of 
therapeutic hypothermia (7, 10, 44, 45).  
 
Table 1.1: Effect of therapeutic hypothermia on death or disability 
 
Forest plot of the effect of therapeutic hypothermia compared with standard care 
(normothermia) on death or disability (“events”) from randomised controlled trials 
including the Total Body Hypothermia (TOBY) trial, the National Institute of Child Health 
and Human Development (NICHD) trial, and the CoolCap trial.  
From “Neurological outcomes at 18 months of age after moderate hypothermia for 
perinatal hypoxic ischaemic encephalopathy: synthesis and meta-analysis of trial data.” 
by Edwards AD, Brocklehurst P, Gunn AJ, Halliday H, Juszczak E, Levene M, Strohm B, 
Thoresen M, Whitelaw A, Azzopardi D. BMJ. 2010 Feb 9;340:c363. 
 
A meta-analysis based on the results of these clinical trials confirmed that therapeutic 
hypothermia commenced within 6 h of birth reduces risks for mortality, death or severe 
neurodevelopmental impairments, and neurological impairments in survivors at 18 
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months corrected age (46). More recent meta-analysis conducted by the Cochrane 
Neonatal Review Group further confirmed that the benefits of cooling on survival and 
neurodevelopmental outcome outweigh the short-term adverse effects such as sinus 
bradycardia and thrombocytopenia (47). Since 2010, therapeutic hypothermia in the 
tertiary centre setting has been recommended for near-term to term newborn infants 
with moderate to severe neonatal encephalopathy in “2010 International Consensus on 
Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science with 
Treatment Recommendations” (48) and was endorsed by the UK National Institute for 
Clinical Excellence (NICE) (49). 
Although clinical evidence supporting the benefit of therapeutic hypothermia following 
perinatal hypoxia-ischaemia is robust, findings from clinical trials newly raised important 
questions around the optimal indication, window of opportunity, cooling modalities, 
target temperature and cooling duration. For example, in two large-scale randomised 
controlled trials of neonatal hypothermia, the primary hypothesis, or the amelioration of 
death or severe neurodevelopmental impairments by 18 months of age in cooled infants, 
has been refuted; the beneficial effect of therapeutic hypothermia has only been shown 
in a subgroup of infants (8) or in the secondary endpoint (7). Especially in a trial which 
used selective head cooling, the treatment appeared to be ineffective for infants with 
relatively smaller body weights or for ones who showed the most severe findings on the 
amplitude-integrated electroencephalogram at admission (50). Interestingly, the impact 
of the body size and the severity of encephalopathy on the efficacy of hypothermia was 
not observed in studies which used whole body cooling (7, 51). Although selective head 
cooling and whole body cooling have been demonstrated to provide similar beneficial 
effects, it is possible that current cooling modalities, especially selective head cooling, 
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might still be optimised by adjusting cooling temperatures for patients’ clinical 
backgrounds and injury patterns. In addition, a number of infants who were randomised 
to normothermia in these trials developed fever greater than 38oC, which was related 
with unfavourable outcomes (7, 45, 50, 52). It is still unclear whether such fever was 
induced by suboptimal temperature control (e.g. excessive warming and sparse body 
temperature monitoring), or was spontaneously induced as a consequence of relatively 
more severe hypoxia-ischaemia. Further studies are required to identify patients who 
are most likely to benefit from therapeutic hypothermia, and to establish cooling 
protocols which provide optimal neuroprotection to infants with different injury patterns 
and clinical backgrounds. 
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1.3  Key factors required to optimise efficacy of therapeutic hypothermia 
1.3.1 Newly raised questions around therapeutic hypothermia 
Although therapeutic hypothermia has now been promoted into a standard of care for 
asphyxiated newborn infants, several important questions were raised relating to the 
optimal application of this treatment. There remains uncertainty about the precise 
temperature reduction, therapeutic time window, duration and method of cooling (whole 
body cooling and/or selective head cooling) that provides optimal neuroprotection (53). 
Furthermore, it is also unknown whether different regions or cell types in the brain are 
protected equally by the same fall in temperature. Although the currently accumulated 
clinical evidence suggests similar neuroprotective effects between whole body cooling 
(7) and selective head cooling (8), no study has compared the difference in the strength 
and type of neuroprotection provided by these cooling modalities.  
 
1.3.2 Cooling modality and brain temperature distribution – normothermia 
and whole body cooling  
As the first step towards studying what are the optimal temperatures for best 
neuroprotection in different brain regions, it is also important to understand the 
temperature gradients within the body and the brain with whole body and selective head 
cooling. From previous studies we know that, in newborn piglets at normal temperature, 
the deep brain temperature is similar to the rectal temperature (Trectal) whereas, because 
of scalp heat loss, the superficial brain is up to 1oC cooler (54-56).  
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Figure 1.6: Temperature distribution under normothermia, whole body cooling 
and selective head cooling in the newborn piglet 
 
 
 
Changes in the rectal (□), 
deep brain (◆), superficial 
brain (△), and scalp skin (●) 
temperatures, and deep to 
superficial temperature 
difference (■) with each 
coolant temperature 
delivered to the cooling cap 
are shown as mean (SD).  
 
From “Brain temperature in newborn piglets under selective head cooling with minimal 
systemic hypothermia.” by Iwata O, Iwata S, Tamura M, Nakamura T, Sugiura M, Ogiso Y. 
Pediatr Int. 2003 Apr;45(2):163-8. 
 
Under whole body cooling, body temperature is reduced without altering subtle 
temperature gradients between body core temperatures and overall brain temperatures 
(57). The majority of experimental studies and clinical trials have used whole body 
cooling because of its simplicity in the temperature control and application (58).  
 
1.3.3 Cooling modality and brain temperature distribution – selective head 
cooling 
Selective head cooling has been used to theoretically minimise the risk for adverse 
systemic effects such as respiratory and cardiac suppression, sympathetic stimulation 
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and coagulation disorders (25, 59). Selective head cooling is induced by a cooling cap 
with simultaneous trunk warming thereby creating large differences between body core 
and both deep brain and superficial brain temperatures (55, 57, 58, 60).  
 
Figure 1.7: Temperature distribution under normothermia, whole body cooling, 
selective head cooling and their combination 
 
 
Diagram depicting the temperature gradients between body core, deep brain and 
superficial brain. Under normothermia and WBC, temperature gradients remain minimum, 
whereas SHC introduces substantial temperature gradients within the body and the brain. 
Abbreviations: WBC, whole body cooling. SHC, selective head cooling. 
 
Temperature control with selective head cooling is more complex compared to whole 
body cooling because of the active thermal flow caused by simultaneous head cooling 
and body warming. Nevertheless, this cooling modality has been applied in two clinical 
trials (8, 44) expecting to accomplish moderate hypothermia in the deep brain structure 
while maintaining slightly higher core body temperature compared to whole body 
cooling. 
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Although little is known about the actual temperature distribution in the human infant 
under therapeutic hypothermia, several experimental studies have investigated the 
temperature of deep brain structures using invasive temperature monitoring (55, 57, 60). 
These studies demonstrated that selective head cooling applied to newborn piglets can 
lower deep-brain temperatures below the body core temperature. The temperature 
difference between the body core and the deep brain has been used as a measure of 
selective head cooling efficiency.  
 
Figure 1.8: Highly efficient surface cooling of the brain while maintaining the 
normal core body temperature in the newborn piglet 
 
Significant head cooling can be achieved while maintaining normothermia in the newborn 
piglet. Values are shown as mean (standard error).  
From “Significant head cooling can be achieved while maintaining normothermia in the 
newborn piglet.” by Tooley JR, Eagle RC, Satas S, Thoresen M. Arch Dis Child Fetal 
Neonatal Ed. 2005 May;90(3):F262-6. 
32 
 
In newborn piglets, using the cooling cap of relatively lower temperatures ~7 to 10oC, 
the deep-brain temperature was lowered up to 9oC below the Trectal with the latter normal 
(56). Given that the deep grey matter is highly vulnerable to hypoxia-ischaemia in the 
term infant (61), it is encouraging that selective head cooling can also provide profound 
hypothermia to the deep brain structure. However, efficient surface cooling inevitably 
increases the intracerebral temperature gradient, resulting in very low superficial brain 
temperatures < 25oC (56). The safety and efficacy of deep hypothermia needs to be 
investigated, as evidence suggests that a temperature “threshold” exists below which 
point hypothermia is sub-optimal or even deleterious because of adverse effects of 
excessive cooling (25, 59, 62, 63).  
 
1.3.4 Cooling modality and spatial protection pattern 
In a clinical trial of selective head cooling, to optimise the balance between the efficacy 
and safety of surface cooling, the cooling cap of ~10 to 20oC was used in combination 
with mild systemic hypothermia to 34 to 35oC (8). However, the exact temperature 
distribution provided by this cooling method remains unknown in newborn infants. If 
hypothermic neuroprotection in a given cerebral region depends on the local tissue 
temperature, selective head cooling may provide spatial neuroprotection patterns 
different from those provided by whole body cooling. An experimental study in a piglet 
model of asphyxial encephalopathy reported that whole body cooling to 35oC provided 
deep-grey-matter dominant neuroprotection as opposed to 33oC which provided more 
profound tissue protection in the cortical grey matter but not in the deep grey matter 
(62).  
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Figure 1.9: Dependence of neuroprotection pattern on the cooling level in the 
piglet model of asphyxial encephalopathy 
 
 
In the piglet model of transient hypoxia-ischaemia (HI), compared to normothermic 
subjects (HI-n), whole body cooling to 35oC (HI-35) provided modest cortical protection 
and favourable deep grey matter protection, whereas whole body cooling to 33oC (HI-33) 
led to optimal cortical protection and less deep grey matter protection.  
From “Depth of delayed cooling alters neuroprotection pattern after hypoxia-ischemia.” 
by Iwata O, Thornton JS, Sellwood MW, Iwata S, Sakata Y, Noone MA, O'Brien FE, 
Bainbridge A, De Vita E, Raivich G, Peebles D, Scaravilli F, Cady EB, Ordidge R, Wyatt JS, 
Robertson NJ. Ann Neurol. 2005 Jul;58(1):75-87. 
 
An observational study which assessed brain magnetic resonance imaging (MRI) of 
infants, who were cooled using either whole body cooling or selective head cooling, 
demonstrated that the latter cooling modality led to relatively more cortical-grey-matter 
dominant protection compared to whole body cooling, which provided global tissue 
sparing (64).  
 
  
34 
 
Table 1.2: MRI findings in representative brain regions and cooling modalities 
 
Newborn infants who were cooled using SHC appeared to have relatively less severe 
cortical lesions, whereas WBC appeared to provide non-region-specific protection.  
From “Mild hypothermia and the distribution of cerebral lesions in neonates with 
hypoxic-ischemic encephalopathy.” by Rutherford MA, Azzopardi D, Whitelaw A, Cowan F, 
Renowden S, Edwards AD, Thoresen M. Pediatrics. 2005 Oct;116(4):1001-6. 
Abbreviations: SHC, selective head cooling. WBC, whole body cooling. BGT, basal 
ganglia and thalamus. WM, white matter. 
 
Another clinical study with a large sample size reported that whole body cooling was 
associated with improved MRI findings in the deep grey matter, posterior limb of the 
internal capsule, and white matter, but not in the cortical grey matter (65), supporting the 
idea that surface cooling of the head may be beneficial for the protection of the cortical 
grey matter. Although it is likely that cooling modality affects the spatial pattern of 
neuroprotection derived from therapeutic hypothermia, further large-scale studies are 
required to identify the exact association between different cooling modalities and 
subsequent neuroprotection patterns, as another clinical hypothermia study suggested 
the association between whole body cooling and cortical protection (66). 
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1.3.5 Variation in regional temperature distribution under therapeutic 
hypothermia 
It is well known that thermogenesis and heat exchange are highly dependent on  
physiological factors such as motion activity, sympathetic stimulation, cardiac function, 
cerebral perfusion, and body size (25, 67), suggesting that these factors need to be 
taken into consideration when monitoring brain temperature using core body 
temperature.  
 
Figure 1.10: Relationship between body core and head core temperatures 
 
Compared to healthy 
newborn infants (○: n=7), 
subjects with cerebral 
damage (●: n=7 including 
three patients with 
hypoxic-ischaemic 
encephalopathy (FUS, VOL 
and TVA), two patients with 
post-haemorrhagic 
hydrocephalus (OZK and 
PUS), one patient with 
hydrocephalus with myelomeningocele (FIN) and one patient with hydranencephaly 
(SKA)) had lower deep brain temperatures, and subjects with low cardiac output (♦: n=2 
including one patient with hypoplastic left heart syndrome (FRA) and one patient with 
unrepairable complex cardiac malformation with ventricular fibrillation (EGG)) had higher 
deep brain temperatures, relative to the oesophageal temperature.  
From “Brain temperature discriminates between neonates with damaged, hypoperfused, 
and normal brains.” by Simbruner G, Nanz S, Fleischhacker E, Derganc M. Am J Perinatol. 
1994 Mar;11(2):137-43. 
36 
 
In newborn infants, who are undergoing therapeutic hypothermia, the proxy brain 
temperature is measured by the core body temperature from either a rectal or 
oesophageal probe (7-9). It is also possible that, compared to whole body cooling, such 
a variation in the regional brain temperature is greater under selective head cooling, by 
which simultaneous head cooling and body warming inevitably cause an active heat 
flow and a substantial temperature gradient. 
 
1.3.6 Determination factors of regional cerebral temperature  
Regional brain temperatures are determined by the balance between the local heat 
production and heat removal; the former is represented by the cerebral metabolic rate of 
oxygen (CMRO2) whereas the latter depends on the cerebral blood flow (CBF) and heat 
dissipation through the scalp (68).  
 
Figure 1.11: Determination factors of local tissue temperature 
 
Diagram depicting elements which may determine the regional tissue temperature. 
Regional temperature levels are determined by the interplay between thermogenesis, heat 
distribution and dissipation to the ambient environment. 
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Previous studies in the newborn infant and newborn preclinical models identified factors 
that determine body/brain temperatures, such as the ambient temperature and humidity, 
and maturity and body size of subjects (69-71), however, associations between the 
brain temperature, metabolism and perfusion have not been fully investigated. In a 
clinical trial which used selective head cooling, the body weight of the infant was 
identified as an important contributing factor to the efficacy of therapeutic hypothermia; 
cooling was not as beneficial for infants with lower body weight as those with higher 
body weights when adjusted for the severity of encephalopathy (50). Pathological 
backgrounds or injury types characteristic to infants with relatively low birth weight might 
also be responsible for the body weight specific benefit of therapeutic hypothermia. 
However, it is also possible that the brain temperature distribution under selective head 
cooling may be significantly altered according to the body size, thus resulting in different 
protection pattern. Further understanding of factors modulating regional cerebral 
temperatures with whole body cooling and selective head cooling may be beneficial to 
improve the efficacy of therapeutic hypothermia.  
 
1.3.7 Techniques used to monitor brain perfusion and metabolism  
As mentioned in the previous section, changes in cerebral perfusion and metabolism 
are both important factors to determine the regional brain temperature. However, the 
dependence of the local brain temperature on the cerebral perfusion and metabolism 
has not been fully investigated in the newborn infant, in part because of the lack in 
non-invasive cotside monitoring technique of these variables. Near-infrared 
spectroscopy (NIRS) for several years now has been used to assess and quantify 
non-invasively brain oxygenation and haemodynamic changes in newborn infants (72, 
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73). Using relatively safe tracers such as oxygen and indocyanine green, NIRS can also 
give crucial information about the cerebral perfusion (74, 75). However, these 
techniques may not be suitable for some infants, because oxygen bolus technique is 
inapplicable when infants are already on 100% oxygen or are well saturated in air; 
intravenous infusion of the dye may be unethical in healthy infants who do not have an 
intravenous cannula, as well as in very sick infants whose cardiac/hepatic function is 
severely impaired.   
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Figure 1.12:  
Cerebral circulation 
variables before and after 
indomethacin 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Significant reductions in circulation variables are demonstrated using NIRS before and 
after the injection of indomethacin.  
From “Effects of indomethacin on cerebral haemodynamics in very preterm infants.” by 
Edwards AD, Wyatt JS, Richardson C, Potter A, Cope M, Delpy DT, Reynolds EO. Lancet. 
1990 Jun 23;335(8704):1491-5. 
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However, recently NIRS has allowed the absolute quantification of brain tissue 
oxygenation and estimation of oxygen metabolism enabling direct and non-invasive 
observation of cerebral oxygen metabolism in the clinical setting (76-79). 
As alternative non-invasive CBF markers, several techniques have been proposed 
using ultrasound Doppler velocimetry (80, 81). Of these, monitoring of the superior vena 
cava (SVC) flow has widely been accepted, based on its strong correlations with the 
flow velocity of cerebral arteries, cerebral tissue oxygenation, and the incidence of 
intra-ventricular haemorrhage in preterm infants (82-85).  
 
1.3.8 Other approaches to improve the efficacy of hypothermic 
neuroprotection 
1.3.8.1 Pre-hospital cooling 
In addition to the investigation for the precise brain temperature control to the specific 
level tailored for each patient and cerebral region, the concern of clinical investigators is 
focused on more practical strategies. In adult patients, pre-hospital and/or intra-arrest 
cooling induced by rapid intravenous administration of cold crystalloids or transnasal 
evaporative have been demonstrated to shorten the time interval required to accomplish 
target temperatures (86, 87). Pre-hospital cooling has also been adopted in clinical 
studies of asphyxiated newborn infants during transportation to the tertiary centre where 
standard cooling is provided. Unlike in adult patients, even passive cooling has been 
demonstrated to provide sufficient temperature reductions in the newborn infant (88-90). 
Although the benefit of early cooling administration has been demonstrated in 
preclinical studies, a considerable fraction of infants who underwent passive cooling in 
these clinical studies experienced excessive cooling under the target range for 
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therapeutic hypothermia at the time of admission (89, 90). Such an unfavourable 
temperature control consequential to passive cooling has been attributed primarily to 
the lack of continuous temperature monitoring during transportation, however, a heat 
buffering device, which can both initiate hypothermia and prevent excessive cooling 
may help improve the early temperature control of asphyxiated infants. Phase changing 
materials (PCMs) are passive heating and cooling substances, usually made of a salt 
hydride, fatty acid and ester or paraffin, such as octadecane (91). PCMs are solid at 
room temperature; when in contact with a warmer object, PCMs liquefy and absorb and 
store heat. Conversely liquid PCMs can solidify and give off heat, thus working as heat 
buffers and stabilising the temperature of whatever is in contact with them.  
 
Figure 1.13: The theoretical heat buffering effect of PCM with a specific melting 
point related to energy exchange 
 
 
Schematic diagram showing the heat buffering mechanism of PCMs. When heat is 
absorbed in solid PCM at a consistent rate, the PCM temperature will increase linearly 
until it reaches its melting point. The PCM temperature will remain at this temperature 
until it all melts; during this period PCM will absorb a larger amount of heat thus acting as 
a heat buffer and stabilising the temperature of whatever is in contact with them. 
Abbreviation: PCM, phase changing material. 
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For example, vests made from PCM are used by firemen, athletes, soldiers and 
surgeons working in hot environments (92); PCMs also have applications in industry 
and housing where they smooth temperature fluctuations (93). Thus, a mattress made 
of PCM blocks may provide safe cooling initiation and its maintenance during 
transportation of infants to tertiary cooling centres. 
 
1.3.8.2 Add-on therapies to therapeutic hypothermia 
Although pharmacological agents have failed to demonstrate their benefit in clinical 
trials (21), attempts to boost the neuroprotective effect of therapeutic hypothermia using 
additional pharmacological treatments have yielded increasing clinicians’ concern (53). 
Recent basic studies have provided a range of treatments targeting new injury 
cascades, such as pro-apoptotic reactions, activation of α2-adrenergic receptors, and 
post-resuscitation intracellular alkalosis, the last of which is caused by the overdrive of 
Na+/H+ exchangers in the neuronal plasma membrane (22). New therapeutic options 
targeting these injury cascades may be expected to ameliorate the neuronal injury in 
combination with or even independent of therapeutic hypothermia. Conventional 
pharmacological agents, such as magnesium sulphate and phenobarbital, might not be 
neuroprotective when used as the monotherapy because of their limited protective 
effect or of short therapeutic time window after hypoxia-ischaemia. Given that 
hypothermia itself has been reported to expand the window of opportunity for other 
neuroprotective interventions (20, 94), these conventional, and hence relatively safer 
options, may still increase the beneficial effect of therapeutic hypothermia. 
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1.4 Cerebral temperature monitoring in preclinical and clinical settings 
1.4.1 Techniques used to monitor brain temperature  
Despite the increasing demand for continuous brain temperature monitoring, the utility 
of direct brain temperature monitoring technique is still of limited value in the clinical 
practice. Unlike in the animal model, direct insertion of invasive temperature probes is 
unethical especially in the newborn infant because of the considerable complications 
such as direct brain damage, haemorrhage and infection secondary to the probe 
insertion. Under normothermia and whole body cooling, deep brain temperature is 
similar to the core body temperatures, thus allowing the use of rectal or oesophageal 
temperatures as a surrogate for the deep brain temperature (57). However, under 
selective head cooling, estimation of the brain temperature is challenging for both the 
superficial and deep brain structures. So far, the nasopharyngeal temperature is 
considered to be an optimal, non-invasive surrogate for the deep brain temperature 
based on the observation in the large animal model (57); accuracy of nasopharyngeal 
temperature monitoring as a surrogate for the deep brain temperature needs to be 
assessed in the clinical case. For the purpose of indirect estimation of the core brain 
temperature, the zero-heat flux technique has been used in the human newborn infant 
(67, 95). This technique enables the estimation of the tissue core temperature by 
nullifying the heat flux from the scalp surface using a piece of heat insulator tightly 
attached over the scalp skin and a temperature probe; for more precise temperature 
estimation and swift equilibrium of the temperature reading, more advanced 
thermometers accomplish zero-heat-flow condition using thermal-compensation probes 
(96). However, these techniques have a limitation in the use under selective head 
cooling, because these methods are likely to warm up the superficial part of the brain to 
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erase the relatively large temperature gradient created by selective head cooling, thus 
potentially interfering efficient cooling. Brain tissue temperature measurement is also 
available using advanced bioengineering techniques, such as the multi-frequency 
microwave radiometer (97) and the water chemical shift of the proton magnetic 
resonance spectroscopy (98).  
 
Figure 1.14: Estimation of local brain temperature using 1H magnetic resonance 
spectroscopy  
 
 
An in vivo calibration piglet spectrum (left-a) and a human brain spectrum (left-b) 
obtained using 'H magnetic resonance spectroscopy single-shot temperature estimation 
techniques. Relationship between the difference in chemical shifts between water and the 
methyl resonance of N-acetylaspartate, and tympanic brain temperature in the newborn 
piglet.  
From “The estimation of local brain temperature by in vivo 1H magnetic resonance 
spectroscopy.” by Cady EB, D'Souza PC, Penrice J, Lorek A. Magn Reson Med. 1995 
Jun;33(6):862-7. 
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Especially the latter can provide 3-dimensional temperature maps, which could be used 
for the validation of other surrogate temperature monitoring techniques. These 
techniques may help enable tailored temperature control in future with further validation 
in the newborn infant.  
 
Figure 1.15: Temperature maps in an adult brain with ischaemic lesion 
 
Maps of voxel temperatures relative to the diffusion weighted imaging for a patient. 
Diffusion weighted imaging shows an ischaemic lesion in the left temporoparietal cortex 
(left panel). Colour maps of regional temperatures per voxel superimposed on a line 
drawing of the diffusion weighted imaging lesion outline for the same patient (right panel). 
From “Measurement of brain temperature with magnetic resonance spectroscopy in 
acute ischemic stroke.” by Karaszewski B, Wardlaw JM, Marshall I, Cvoro V, Wartolowska 
K, Haga K, Armitage PA, Bastin ME, Dennis MS. Ann Neurol. 2006 Oct;60(4):438-46. 
 
 
1.4.2  Utility of the piglet model for the investigation of brain temperature 
distribution  
Newborn piglets have been widely accepted as a translational model suitable to assess 
the temperature distribution under therapeutic hypothermia (55-57, 60). A normal 
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term-born piglet has greater body weight, greater brain to body volume ratio, and a 
more mature brain compared to rodents (99, 100). 
 
Figure 1.16: Coronal MRI of newborn mouse pup, piglet and human brains 
 
Coronal slices demonstrating the difference in the size and anatomical structure of the 
brain from different species. The brain of the newborn piglet, although still smaller 
compared to the human brain, is likely to allow more practical estimation of cerebral 
temperature distribution under different intrinsic and extrinsic conditions. 
 
There still remain substantial differences in the size, proportion and anatomical structure 
of the brain and the surrounding tissue between human infants and piglets, and hence, 
caution is still required to interpret the findings in the piglet model to the human newborn 
infant. Nevertheless, findings from these preclinical studies have helped determine the 
target core body temperatures for the clinical trials, which are likely to accomplish 
sufficient cooling levels in the deep brain structure, and further fine-tuning of therapeutic 
hypothermia and additional neuroprotective treatments may benefit from the model 
especially when a procedure needs to be assessed in a clinically relevant setting by 
incorporating multiple physiological factors.  
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Chapter 2 
Aims and Hypothesis 
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2.1  Aim 
 
1. To investigate the temperature distribution and its associated factors under induced 
hypothermia in the newborn piglet 
2. To highlight the associations between the ambient temperature, body size, cerebral 
metabolism, perfusion and body/brain temperatures in healthy newborn infants 
using non-invasive techniques 
3. To establish a non-electronic cooling device, which provides safe and stable cooling 
in low resource settings or during transport to a tertiary cooling centre 
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2.2 Hypotheses 
 
1. In the piglet model under induced cooling, brain temperatures are associated with 
the body size. 
2. In healthy normothermic newborn infants, brain temperatures are associated with 
the ambient temperature, body size, cerebral blood flow and metabolism. 
3. In the normothermic newborn infant, brain perfusion and metabolism are positively 
coupled between each other to suffice the tissue energy demand. 
4. Using a mattress made of PCM, whole body cooling can be initiated and maintained 
with more stable body temperatures compared to water bottles. 
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Chapter 3 
Determinants of regional cerebral temperatures in newborn piglets  
under selective head or whole body cooling 
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3.1  Methods 
3.1.1 Summary 
This chapter presents the first part of the study. The aim was to prove the hypothesis 
that, in the piglet model, brain temperatures are dependent on the body size under 
induced cooling. Temperature distribution in the brain and body was investigated under 
normothermia, whole body cooling and selective head cooling.  
 
- Ethical approval of this study 
Experiments were performed under UK Home Office Licence in accordance with UK 
guidelines. 
 
3.1.2 Subject preparation 
Within 24 h of birth, 14 healthy Large-White piglets born at term were randomly selected 
for whole body cooling (4 females and 3 males, mean body weight (standard deviation 
(SD)), 1.46 (0.44) kg) or selective head cooling (3 females and 4 males, 1.40 (0.32) kg). 
 
3.1.3 Anaesthesia and surgical procedures 
Piglets were sedated with intramuscular midazolam (0.2 mg/kg), and the percutaneous 
arterial oxygen saturation (SpO2) was monitored using a pulse oximeter (8600 FO; 
Nonin Medical, Plymouth, MN, U.S.A.). Five percent isoflurane was given as the initial 
concentration through a facial mask during the insertion of the tracheostomy tube. 
Anaesthesia was maintained by the combination of isoflurane (3% during the surgical 
procedures and 2% for the rest of the procedures), nitrous oxide, and a continuous 
infusion of fentanyl (5-10 μg/kg/h). After the insertion of the tracheostomy tube, piglets 
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were ventilated mechanically with ventilator settings adjusted to maintain PaO2 and 
PaCO2 levels at 8 to 13 kPa and 4.5 to 6.5 kPa, respectively. The blood gas was 
analysed allowing for the temperature correction to the Trectal of the subject (pH-stat). 
We preferred this method to the alpha-stat (blood samples analysed at 37oC and 
reported without correction regardless of the patient’s body temperature) to monitor 
blood gas tensions and their physiological effects at the patient’s body temperature. 
Although both the pH-stat and alpha-stat have widely been used in clinical studies (8, 
45), there is a trend that the pH-stat is more frequently used in young patients including 
newborn infants and children, presumably because of the increased risk of hypocarbia 
and subsequent reduction in CBF when the alpha-stat is used (101, 102). An umbilical 
venous catheter was inserted for the continuous infusion of maintenance fluids (10% 
dextrose, 60 ml/kg/day), morphine, and intravenous injections of antibiotics (50 mg/kg 
benzylpenicillin and 2.5 mg/kg gentamicin, every 12 h). An umbilical arterial catheter 
also was inserted to enable continuous monitoring of the heart rate and arterial blood 
pressure, and intermittent blood sampling to measure PaO2, PaCO2, pH, electrolytes, 
glucose, and lactate. Bolus infusions of colloid (Gelofusin; Braun Medical, 
Emmenbrucke, Switzerland) and dopamine infusions (5-15 μg/kg/min) were used as 
required to maintain the mean arterial blood pressure greater than 40mm Hg. During 
surgery, Trectal was maintained normothermic for the newborn piglet (38.5 ± 0.5°C). 
Following surgery, the piglet was positioned prone (head immobilized) in a plastic 
cylindrical pod. 
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Figure 3.1: Surgical preparation of the piglet model 
 
Surgical preparation of the piglet model under general anaesthesia using isoflurane. 
Physiological variables were continuously monitored as in the clinical intensive care 
setting. The core body temperature was controlled using a cooling blanket, which was 
circulated by temperature controlled water.  
A: multi-channel fibre-optic thermometer, B: electronic cooling machine, C: end-tidal 
capnometer, D: radiant heater, E: piglet inserted within a plastic pod, F: polygraph for 
heart rate, blood pressure and body temperatures, G: pulse-oxymeter and H: ventilator 
and gas blender.
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3.1.4 In vivo temperature measurement 
These studies coincided with the calibration of magnetic resonance regional 
temperature measurements: apart from the period when the animal was allowed to 
recover and to be stabilised after surgical procedures (~30 - 60 min), all in-vivo 
temperatures were measured within a 7 Tesla MR scanner.  
 
Figure 3.2: Temperature maps using magnetic resonance spectroscopic imaging 
techniques in a representative piglet 
 
 
Scout magnetic resonance imaging (left) and representative maps of brain temperature 
under whole body cooling (right, upper panel) and selective head cooling (right, lower 
panel), showing remarkable temperature distributions specific to both cooling modalities 
and cooling levels. Rectal temperatures are shown at the bottom of temperature maps. 
From “Cerebral Temperature Mapping by Magnetic Resonance Spectroscopy in a Model 
of Total Body and Selective Head Cooling.” by Thornton, J. S. Cady, E. B. 
Shanmugalingam, S. Ordidge, R. J. Iwata, O. Iwata, S. Wyatt, J. S. Robertson, N. J. 
Pediatric Academic Societies Annual Meeting, Washington DC, USA. 2005:p2681. 
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Temperature probes were calibrated between 20 and 40oC using a water bath and 
standard mercury thermometer. Over this temperature range, all probes showed 
temperature measures within 0.1oC of the standard thermometer. A thermistor probe 
(Arbo N44-91, Kendall, Powell, TN, U.S.A.) was inserted to 5 cm depth from the anal 
sphincter to measured Trectal. To measure the brain temperature 5, 10, 15 and 20 mm 
from the brain surface (T5, T10, T15, and T20 respectively), a multi-channel fibre-optic 
probe (MR compatible, SMM, Luxtron Corporation, Santa Clara, CA, U.S.A.) was 
inserted 23 mm subdurally into the striatum via a right-cranial burr-hole 1 cm lateral to 
and 1 cm posterior to the bregma.  
 
Figure 3.3: In-vivo temperature monitoring 
 
 
 
 
 
Brain temperatures between 5 and 20 mm 
from the brain surface were monitored 
using a multi-channel fibre-optic probe 
inserted towards the striatum (yellow 
arrow). 
 
 
 
The dural aperture was minimised to reduce the leakage of the cerebrospinal fluid and 
air inflow. After the insertion of the brain temperature probe, the scalp was sutured, and 
the probe was tightly fixed to the scalp surface using the surgical tape. The anatomical 
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location of the probe was ascertained retrospectively using MRI, and then, with 
post-mortem brain slices, however, to minimise traumatic brain injury and haemorrhage 
associated with instrumentation, the probe was positioned once only. 
 
Figure 3.4: Cooling device used for selective head cooling in the piglet model 
 
 
 
 
 
 
 
 
 
A cooling cap was attached to the head of the animal to minimise the free space between 
the cap and the scalp skin. 
 
Figure 3.5: Insertion of the pod into the bore of the magnetic resonance scanner   
 
The data acquisition was performed within a specially designed plastic pod, in which 
animals were mechanically ventilated under general anaesthesia (left). The pod was then 
inserted into the bore of the magnetic resonance scanner (right). 
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After the surgical procedures, piglets were positioned prone within a plastic pod; the 
scalp of the animal was firmly immobilised below the surface coil; the pod was inserted 
into the bore of the magnet. Trectal was varied using a mattress applied over the ventral 
and dorsal trunk, through which temperature-adjustable water circulated (K20, Haake, 
Thermo Electron Corporation, Waltham, MA, U.S.A.). For subjects which underwent 
selective head cooling, in addition to the mattress, a flexible plastic cap, through which 
temperature-controlled water circulated (Cool Care System, Olympic Medical, Seattle, 
WA, U.S.A.), was positioned so as to contact the entire scalp above the orbit and nostril 
midpoint, infraorbital margin, occipital torus, and the midpoint between the mandibular 
angle and external auditory meatus. The cap covered a similar relative scalp area for all 
head sizes. 
 
3.1.5 Experimental protocol  
Temperature values were recorded every minute from the brain and every 15 min from 
the pod interior, coolants and rectum. After normothermic stabilisation and baseline 
temperature measurements, whole body cooling or selective head cooling were 
commenced. For whole body cooling, mattress water temperature was decremented to 
attain each successive target Trectal of 36.5, 34.5, 32.5, and 30.5oC. For selective head 
cooling, measurements were made firstly with Trectal normothermic and the cooling-cap 
in situ but void of coolant. The cap temperature was then adjusted sequentially to 20, 15, 
and 10oC whilst keeping Trectal normothermic by increasing mattress temperature 
applied to the trunk. Then the mattress temperature was lowered to maintain Trectal at 
34.5oC, and cap temperatures of 10, 15 and 20oC were applied again. The final 
measurements were made with no circulating cap water (whole body cooling at Trectal 
58 
 
34.5oC without selective head cooling). Temperature stability was defined as Trectal within 
0.5oC of the target temperature and both this and regional brain temperatures varying 
by less than 0.2oC for 15 min. It generally took 2 to 4 h for each target Trectal until the 
establishment of stable brain and body temperatures for each setting. 
 
Figure 3.6: Detection of the position for the temperature probe end 
 
A coronal slice of the brain which was harvested, perfusion fixed, post fixed, and sliced 
with the thickness of ~5 mm. Broken line, the trace of the probe; Red arrow, the end of the 
probe; the blue arrow, the caudate head towards which the probe was inserted.   
 
After each experiment the animal was humanely sacrificed by injecting an overdose of 
intravenous pentobarbitone and the brain was perfusion fixed using phosphate saline 
buffer and 4% paraformaldehyde. The brain was then dissected out, post-fixed using 
2% paraformaldehyde, and sliced to 5 mm thickness. The distance from the probe tip to 
the centre of the caudate-nucleus was measured to assess the influence of the body 
size on the location and the temperature reading at the deep brain structure. 
Haematoxylin and eosin staining was used to examine slices for lesions associated with 
the temperature probe insertion. 
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3.1.6 Data analyses 
Relative temperature values of deep brain to rectal (Trectal – T20), rectal to superficial 
brain (Trectal – T5) and deep brain to superficial brain (T20 – T5) temperatures were 
calculated in order to self-correct for inter-subject and intra-subject body core 
temperature variations. Physiological data were inspected for normality and equality of 
variance. Repeated measures analysis of variance was used to examine the effects of 
magnetic field on the heart rate, mean arterial blood pressure, and brain temperatures. 
Primary outcomes were the linear body weight dependences of the absolute and 
relative cerebral temperatures for each temperature setting. In addition to the univariate 
general linear model, multivariate analysis was used to elucidate the contribution of the 
putative brain temperature modulators, such as the body weight, target Trectals and target 
cap temperatures. Post-hoc analyses employed the Bonferroni test and p-values were 
corrected for multiple comparisons. For clarity, tabulated temperatures were corrected 
to the mean body weight of the whole body cooling group or selective head cooling 
group using the multivariate technique.  
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3.2 Results 
3.2.1 Summary 
In this chapter, the results of the first part of the study “determinants of regional cerebral 
temperatures in newborn piglets under selective head or whole body cooling” are 
presented. Under normothermic condition, a lower body weight of the piglet led to a 
lower superficial brain temperature (p < 0.01). Deep brain to superficial brain and rectal 
to superficial brain temperature gradients increased with decreasing body weight (both 
p < 0.05). When whole body cooling was applied, a lower body weight led to a lower 
superficial brain temperature and a higher rectal to superficial-brain temperature 
gradient (p < 0.05 and p < 0.01 respectively). Under selective head cooling, a lower 
body weight was associated with lower temperatures in the superficial brain and deep 
brain (p < 0.01 and p < 0.05 respectively), whereas a lower body weight led to greater 
rectal to deep brain, rectal to superficial brain, and deep brain to superficial brain 
temperature gradients (p < 0.05, p < 0.01 and p < 0.05 respectively). Compared with 
selective head cooling alone, superimposition of whole body cooling (34.5oC) reduced 
all regional temperatures (all p < 0.001), however, the temperature gradients were not 
affected. 
 
3.2.2 Associations between regional cerebral temperatures and the body 
weight 
3.2.2.1 Intracranial temperature gradient and body weight 
Results are shown as mean (SD) unless otherwise stated. Significance was assumed 
for p < 0.05. 
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3.2.2.2 Temperature probe location and trauma 
One piglet which underwent selective head cooling was excluded from analysis 
because the probe tip was > 1 cm from the caudate nucleus, leaving the selective head 
cooling group consisting of 2 females and 4 males with body weight 1.45 (0.31) kg. 
Otherwise, the probe tip was 0.4 (0.2) cm and 0.5 (0.3) cm deeper than the head of the 
caudate nucleus in whole body cooling and selective head cooling piglets respectively 
(overall 0.4 (0.3) cm), and this distance was independent of the body weight in the entire 
population and both cooling groups. No cerebral macroscopic or microscopic lesions 
were discovered apart from a little blood along the probe path. 
 
3.2.2.3 Physiological variables under normothermia, whole body cooling 
and selective head cooling 
Two piglets which underwent whole body cooling developed severe hypotension and 
bradycardia at target Trectal 30.5oC; ventilator failure terminated one experiment in a 
piglet which was assigned to selective head cooling before collecting data at target Trectal 
34.5oC: physiology data for the quoted Trectal targets in these 3 piglets were excluded 
from analysis.  
The heart rate, mean arterial blood pressure, and Trectal were invariant with respect to 
both the 7 Tesla magnetic field and magnetic resonance data acquisition: these were 
38.3 (0.9) oC, 161 (25) min-1, and 60.3 (11) mmHg respectively before entering the 
magnetic resonance scanner and 38.2 (1.1) oC, 163 (26) min-1, and  60.7 (12) mmHg 
shortly after entry.  
In the whole body cooling group, the heart rate was reduced at 34.5oC (134 (28) min-1, n 
= 7, p < 0.05), 32.5oC (122 (29) min-1, n = 7, p < 0.01) and 30.5oC (91 (20) min-1, n = 5, p 
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< 0.001) compared to normothermia (176 (25) min-1); mean arterial blood pressure was 
altered only at 30.5oC (36 (6) mmHg; n = 5, p < 0.05) compared to normothermia (48 (9) 
mmHg). The heart rate and mean arterial blood pressure were unaffected by selective 
head cooling alone (n = 6). During selective head cooling with whole body cooling (n = 5, 
target Trectal 34.5oC), the mean arterial blood pressure was invariant from the value 
under the normothermic condition; however, the heart rate was reduced with cap 
cooling off (141 (15) min-1, p < 0.001) and on (144 (17) min-1 at 20oC, 139 (19) min-1 at 
15oC, and 139 (25) min-1 at 10oC, all p < 0.01) compared with baseline (normothermic 
Trectal and cap cooling off, 196 (26) min-1).   
 
3.2.2.4 Temperature distribution under normothermia  
 (n = 13, univariate analysis) 
Under normothermic Trectal before the commencement of active cooling, T5, T10, and T15 
were linearly correlated with the body weight (p = 0.003, 0.006 and 0.030 respectively) 
(See Fig. 3.7 (A)), however, T20 was not dependent on the body weight. Trectal – T20 was 
~0oC and was not dependent on the body weight (See Fig. 3.7 (B)). In contrast, relative 
brain temperatures of T20 – T5 and Trectal – T5 were both negatively associated with the 
body weight (p = 0.010 and 0.011 respectively) (See Fig. 3.7 (C)-(D)).  
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Figure 3.7: Associations between rectal temperature, regional brain 
temperatures and the body weight under normothermic condition 
 
(A) neither Trectal (○) nor T20 (deep brain temperature; X) depended on the body weight; 
however, T5 (superficial brain temperature; ▲) decreased as the body weight fell (p < 0.01). 
(B). Trectal - T20 was ~ 0oC and was not dependent on the body weight. (C) T20 - T5 and (D) 
Trectal - T5 both increased linearly as body weight decreased over the experimental range 
(both p < 0.05). Regression lines are from univariate analyses with p < 0.05 (shown in red 
for T5 in panel (A)). 
  
64 
 
3.2.2.5 Temperature distribution under whole body cooling  
 (n = 7, multivariate analysis) 
With whole body cooling, a lower target Trectal was associated with a lower T20, T15, T10, 
and T5 (all p < 0.001) (See Fig. 3.8 (A) and Table 3.1). Relative temperatures of Trectal – 
T20, T20 – T5, and Trectal – T5 were independent of target Trectal. A lower body weight was 
associated with a lower T5 and a higher Trectal – T5 (p = 0.034 and 0.008 respectively) 
(See Fig. 3.8 (B)). T10, T15, T20, Trectal – T20 and T20 – T5 were not dependent on the body 
weight. 
 
Table 3.1: Regional and relative temperatures for whole body cooling at each 
target rectal temperature (°C, mean (standard error); n = 7; corrected to 
the mean body weight of 1.46 kg) 
 
Temperature 
measures 
Target Trectal  
38.5 ºC 36.5 ºC 34.5 ºC 32.5 ºC 
Trectal  38.5 (0.1) 36.6 (0.2) 34.4 (0.2) 32.5 (0.2) 
T5 38.1 (0.2) 36.4 (0.2) 34.0 (0.2) 31.9 (0.3) 
T10 38.3 (0.2) 36.6 (0.2) 34.5 (0.3) 32.2 (0.3) 
T15 38.4 (0.1) 36.6 (0.2) 34.4 (0.2) 32.4 (0.3) 
T20 38.5 (0.2) 36.8 (0.2) 34.5 (0.2) 32.6 (0.2) 
Trectal -T20 0.0 (0.2) 0.2 (0.1) 0.1 (0.2) 0.1 (0.1) 
T20 - T5 0.4 (0.1) 0.4 (0.2) 0.5 (0.2) 0.6 (0.3) 
Trectal - T5 0.4 (0.1) 0.2 (0.2) 0.3 (0.1) 0.5 (0.2) 
 
 
65 
 
Figure 3.8: Associations between brain temperatures and the body weight with 
whole body cooling 
 
(A) T5 and (B) Trectal - T5 at target Trectal of 38.5 (○), 36.5 (), 34.5 (Δ), 32.5 (○), and 30.5oC 
(X). Regression lines are from univariate linear regression analyses with p < 0.05: in panel 
(A) for normothermia (red); and in panel (B) red - normothermic, blue - target Trectal 36.5oC, 
and green - target Trectal 34.5oC. 
 
3.2.2.6 Temperature distribution under selective head cooling without 
whole body cooling  
(n = 6, multivariate analysis) 
As the temperature of the cooling cap decreased, T5 (p = 0.004), T10 (p = 0.002), T15 (p = 
0.001), and T20 (p = 0.001) all fell, whereas relative temperatures of Trectal – T20 (p = 
0.001) and Trectal – T5 (p = 0.006) both increased (T20 – T5 not significant) (See Table 3.2 
and Figs. 3.9 (A)-(E)). A smaller body weight was linearly associated with a lower T5 (p = 
0.007), T10 (p = 0.019), T15 (p = 0.023), and T20 (p = 0.017) (See Figs. 3.9 (A)-(B)), 
whereas relative temperatures of Trectal – T20 (p = 0.020), T20 – T5 (p = 0.029) and Trectal – 
T5 (p = 0.009) were inversely correlated with the body weight (See Figs. 3.9 (C)-(E)). A 
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lower cap temperature and a smaller body weight were synergistically associated with 
even a lower T10 (p = 0.019), T15 (p = 0.007), and T20 (p = 0.005) (See Fig. 3.9 (A)), and 
even a greater relative temperature of Trectal – T20 (p = 0.006) (See Fig. 3.9 (C)). 
 
Table 3.2: Regional and relative temperatures for selective head cooling with 
normothermic rectal temperature (°C, mean (standard error), n = 6, 
corrected to the mean body weight of 1.45 kg) 
 
Temperature 
measures  
Cooling Cap 
off 20ºC 15ºC 10ºC 
Trectal  38.9 (0.1) 38.5 (0.2) 38.5 (0.2) 38.5 (0.1) 
T5 38.0 (0.2) 33.2 (1.7) 26.3 (1.0) 23.4 (1.4) 
T10 38.2 (0.1) 34.4 (1.7) 29.3 (1.2) 27.0 (1.5) 
T15 38.4 (0.1) 36.2 (1.0) 33.2 (0.9) 31.5 (1.1) 
T20 38.3 (0.0) 36.9 (0.7) 35.3 (0.7) 34.1 (0.7) 
Trectal -T20 0.5 (0.1) 1.5 (0.6) 3.2 (0.6) 4.4 (0.7) 
T20 - T5 0.4 (0.2) 3.8 (1.1) 8.9 (0.8) 10.6 (1.3) 
Trectal - T5 0.9 (0.3) 5.3 (1.6) 12.2 (1.1) 15.0 (1.5) 
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Figure 3.9: Associations between regional and relative brain temperatures and 
the body weight for selective head cooling without whole body 
cooling 
 
  
No cooling (○), and cooling cap at 
20 (□), 15 (Δ), and 10oC (X). 
Regression lines: black - no 
cooling; red - 15oC; and blue - 10oC 
from univariate regression 
analyses with p < 0.05. 
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3.2.2.7 Temperature distribution under selective head cooling with 
superimposed whole body cooling  
 (n = 5, multivariate analysis) 
Due to the interruption of the data collection in one piglet (see 3.2.2.3 Physiological 
variables under normothermia, whole body cooling and selective head cooling), only the 
data from 5 piglets were analysed. Compared to selective head cooling alone, 
superimposition of whole body cooling (target Trectal 34.5oC) reduced all regional 
cerebral temperatures (all p < 0.001), however, relative temperatures of Trectal – T20, T20 – 
T5 and Trectal – T5 were not affected (See Table 3.3).  
 
Table 3.3: Regional and relative temperature differences for selective head 
cooling with target rectal temperature of 38.5°C and 34.5°C  
 (°C, mean (standard error), p; n = 5, corrected to the mean body 
weight of 1.45 kg)  
Temperature measures 
Temperature difference with target Trectal 
38.5 vs. 34.5ºC 
Trectal 4.0 (0.1), p=0.000 
T5 4.3 (0.7), p=0.010 
T10 3.5 (0.6), p=0.012 
T15 4.0 (0.5), p=0.003 
T20 4.0 (0.4), p=0.002 
Trectal - T20 0.0 (0.4), NS 
T20 - T5 -0.8 (0.4), NS 
Trectal - T5 -0.8 (0.8), NS 
Pair-wise comparison by paired t-test with Bonferroni correction 
Abbreviation: NS, not significant. 
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3.2.2.8 Relationships between relative temperatures  
 (univariate analysis) 
When temperature measurements at all target cooling levels were incorporated, there 
were significant linear relationships between Trectal – T5 and Trectal – T20, and between 
Trectal – T5 and T20 – T5 for whole body cooling (p = 0.020 and p < 0.001 respectively), 
and between all the relative temperatures with selective head cooling (all p < 0.001) 
(See Fig. 3.10, data only shown for Trectal – T5 and T20 – T5). 
 
Figure 3.10: Relationships between relative temperature of Trectal – T5 and  
 T20 – T5 
 
When whole body cooling (X) and selective head cooling (Δ) measurements at all cooling 
temperatures were separately incorporated, T20 - T5 (intracerebral temperature gradient) 
correlated linearly with Trectal - T5 (rectal to superficial brain temperature gradient) for both 
cooling modalities (both p < 0.001). Temperature gradients were considerably greater for 
selective head cooling. Regression lines: red – whole body cooling; black – selective 
head cooling. 
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3.3 Brief Discussion 
3.3.1 Summary 
We have proved the hypothesis that brain temperatures are associated with the body 
size under induced cooling in the piglet model. The findings of this study are discussed 
in this chapter.  
 
- Key Findings from this Study: 
Brain cooling under whole body cooling, selective head cooling, or even normothermia 
was more efficient with lower body weight, presumably due to greater head surface area 
to volume ratios. The association between brain temperatures and the body weight was 
more prominent with selective head cooling compared to whole body cooling and 
normothermia, suggesting that infants with low body weight may be at an increased risk 
of excessive cooling. Cooling may require adjustment to the body weight to accomplish 
consistent regional temperatures and optimal neuroprotection while undergoing 
therapeutic hypothermia. 
 
- What is already known and what our study adds: 
What is already known: 
 Both whole body cooling and selective head cooling can ameliorate death or severe 
neurodevelopmental impairments at least to 18 months old in infants with moderate 
to severe neonatal encephalopathy. 
 Cooling was inefficient to several groups of infants, such as most severely 
asphyxiated infants defined by amplitude integrated encephalogram, and infants 
whose body weight was less than the quartile of the entire population.  
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What our study adds: 
 Brain cooling, including whole body cooling, selective head cooling, and even 
natural cooling with normothermic condition, was more efficient with smaller body 
size, suggesting that smaller subjects are at increased risks to be overcooled.    
 Temperature differences between the body core, deep brain and superficial brain 
were positively coupled between each other with selective head cooling, suggesting 
that efficient surface cooling is inevitably accompanied by a large intracerebral 
temperature gradient, resulting in excessive cooling in the superficial brain. 
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3.3.2 Regional cerebral temperature and body weight 
Brain temperature is determined by metabolic heat production, heat delivery or removal 
via the CBF, and heat exchange at the body surface through convection, radiation and 
evaporation (54). The contribution of each factor varies with specific physiological and 
pathological conditions, such as cardiac output, spontaneous activity, sleep – wake 
status, ambient temperature and humidity, and maturation of the skin. In this study, we 
have demonstrated that, even with normothermia, regional brain temperatures were 
associated with the body weight. At first glance this may be counter-intuitive. However, 
heat is continuously lost from the scalp, the amount of which depends on the head 
surface-area to volume ratio. In a simple sphere model, this ratio is inversely 
proportional to the radius and, hence, larger for smaller spheres.  
 
Figure 3.11: Heat dissipation from the scalp surface: simulation in a sphere model 
 
Cartoon depicting the influence of the head size to the heat dissipation from the scalp 
surface. As the head of the newborn infant is regarded as a sphere, a smaller head is 
likely to lose more heat from the scalp surface compared to a larger head, because of the 
greater surface to volume ratio. 
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Since heat loss may be proportional to head surface area and generation proportional to 
brain volume, smaller piglets may have more efficient heat dissipation and lower 
cerebral temperatures. We observed even more prominent associations between 
regional brain temperatures and the body weight of the animal with selective head 
cooling, which might explain the patient specific efficacy of therapeutic hypothermia 
using this modality (50). Caution is still required, because the coupling between brain 
temperatures and the body weight can in part be explained by the 
maturation-dependent cerebral metabolism i.e. more matured (and hence larger) 
subjects are likely to have higher cerebral metabolism than their peers (79, 103), 
resulting in greater local thermogenesis and higher brain temperature. However, given 
that experimental piglets are generally born within a few days of term (115 days), the 
difference in the body size may reflect the nutritional state during the fetal period rather 
than that in maturation (104). Future studies need to address the variation and 
dependence of cerebral metabolism and perfusion on the body size in our piglet model. 
 
3.3.3 Clinical Implications: Normothermic low birth weight infants 
Term low birth weight infants are likely to have lower superficial brain temperatures 
even when systemically normothermic. It is possible that lower regional brain 
temperatures in low body weight infants (and also higher regional brain temperatures in 
large body weight infants) could contribute in part to the regional pathophysiological 
characteristics of neonatal encephalopathy which are specific to particular gestational 
ages and body sizes (105). Future experimental and clinical studies should explore 
relationships between the spatial pattern of brain injury, body weight and regional brain 
temperatures.
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3.3.4 Clinical Implications: Selective head cooling or whole body cooling  
Increasing evidence indicates the existence of a “threshold” temperature below which 
the balance between protective and injurious effects of therapeutic hypothermia is 
weighted towards the latter (25, 58, 62, 63). In a clinical trial which used selective head 
cooling with mild whole body cooling to 34.5oC, subgroup analysis revealed that cooled 
infants with the birth weight of less than the quartile of the entire population had 
significantly worse outcome compared to their peers in the hypothermia group. 
Multivariate analysis demonstrated that cooling, lower encephalopathy grade, and lower 
birth weight were associated with better outcomes, whereas there was a signiﬁcant 
interaction between treatment and birth weight, such that larger infants showed a lower 
rate of favourable outcomes in the normothermic group but greater improvement with 
cooling (50). In our study population which underwent selective head cooling, at each 
temperature for the cooling cap, the brain of animals with smaller body weight was 
cooled more efficiently; this relationship was most apparent in the superficial brain. We 
speculate that, in the clinical trial of selective head cooling (50), the infants with lower 
body weight did not benefit from cooling because excessive cooling upset the beneficial 
effect of the treatment (63, 106-108).  
 
75 
 
Table 3.4: Influence of the body weight on the outcome of the infants in a 
randomised controlled trial of selective head cooling 
 
 
In a multivariate analysis, cooling, lower encephalopathy grade and lower birth weight 
were associated with better outcomes. Larger infants ≥25th percentile showed a lower 
rate of favourable outcomes in the control group but greater improvement with cooling.  
From “Determinants of outcomes after head cooling for neonatal encephalopathy.” by 
Wyatt JS, Gluckman PD, Liu PY, Azzopardi D, Ballard R, Edwards AD, Ferriero DM, Polin 
RA, Robertson CM, Thoresen M, Whitelaw A, Gunn AJ; CoolCap Study Group. Pediatrics. 
2007 May;119(5):912-21. 
 
Our results also suggest that cerebral to rectal and deep brain to superficial brain 
temperature gradients were tightly coupled between each other. In a study which used 
the newborn piglet, Tooley et al., demonstrated that the deep brain temperature can be 
lowered up to 9oC while maintaining normal Trectal, using selective head cooling with the 
cap temperature below 10oC (56). The authors proposed that such a selective head 
cooling strategy could be used for preterm human infants. However, it is important to 
point out that very efficient selective head cooling will simultaneously produce an 
excessively low superficial brain temperature. Given that the safety and efficacy of 
prolonged deep hypothermia has not been investigated to the developing brain, it is 
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suggested that higher cap temperatures should be used in smaller infants to induce less 
profound superficial cooling. 
 
It is well known that spatial injury patterns following perinatal hypoxia-ischaemia vary 
between infants (109). A study in a piglet model of asphyxial encephalopathy observed 
that the protection pattern of whole body cooling at 35oC and 33oC was spatially 
different, with the former providing deep grey matter dominant protection and the latter 
cortical grey matter dominant tissue sparing (62). Taken together, it is suggested that 
optimal neuroprotection may require region- and patient-specific cooling temperatures. 
Carefully tailored selective head cooling combined with whole body cooling may help 
“deliver” the optimal temperature for protection to the regional brain tissue, 
subsequently providing maximum tissue protection. Our results suggest that the body 
weight is a critical factor in optimising brain temperature control during therapeutic 
hypothermia, especially selective head cooling. Further studies are needed to 
determine the optimal regional temperatures which maximise neuroprotection for each 
injury pattern. Importantly, even with whole body cooling alone, a lower body weight was 
associated with a lower superficial brain temperature by up to ~2oC, implying that, 
without care, the brain tissue temperature of the cortical grey matter may be highly 
various between subjects, potentially resulting in different protection pattern in the 
superficial brain structure. Further studies using MRI in infants who underwent whole 
body cooling and selective head cooling are required to clarify the dependence of 
cortical grey matter protection on the infant’s body and head size. 
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3.3.5 Limitations of the Temperature study 
The current study was conducted within the bore of the magnetic resonance 
spectrometer. The influence of magnetic resonance environment was, if any, similar 
throughout the study population. Nevertheless, the effect of a 7 Tesla magnetic field on 
the brain cannot be totally ignored; for example, even the data acquisition of MRI and 
magnetic resonance spectroscopy might give heat to the brain tissue (110). In our 
current study, physiological variables were similar before and after the insertion of the 
piglet’s pod into the bore of the scanner. Of the magnetic resonance techniques used in 
our routine sequence, spectroscopic imaging supplied the highest power but less than 
half the clinical study limit (2 W/kg for the brain), which was defined for patients and 
volunteers undergoing clinical magnetic resonance diagnostic procedures (111); other 
methods within our routine, such as diffusion tensor imaging and single voxel magnetic 
resonance spectroscopy, generated less power. No significant physiological changes 
have been reported in humans up to 8 Tesla (112). In conclusion, the magnetic 
resonance environment was unlikely to have affected cerebral temperatures 
significantly in our current study. 
The temperature probe was positioned consistently in the animal’s brain except for a 
piglet in which the probe end was unacceptably dislocated, and the temperature data of 
which were excluded from the analysis. However, it is still possible that the deep brain 
temperature in a larger animal was underestimated (and hence Trectal – T20 was 
overestimated and T20 – T5 was underestimated) especially with selective head cooling, 
because of the larger temperature gradient. However, for whole body cooling or 
selective head cooling, the depth of the temperature probe was independent of the body 
weight, suggesting the influence of minimal, if any, bias. 
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We related the cerebral temperature to the body weight rather than the head diameter 
or circumference, because the anatomy of the piglet’s head rendered these measures 
inappropriate. Future studies should utilise the volumetric brain MRI technique and 
analyses which incorporate the scalp or brain surface. 
Because of the limited number of subjects available for the current study, we were 
unable to include several important variables. For example, our current study subjects 
did not undergo hypoxic-ischaemic insult because hypoxia-ischaemia render intensive 
life support under deep hypothermia even more difficult. Careful interpretation of the 
current findings is required, because the pattern of CBF and brain metabolism may be 
specific to each subject, presumably depending on various factors such as the maturity, 
insult severity, extracerebral pathology, infection, and inflammation (16, 113, 114). 
These patient specific factors may in themselves engender intrinsic cerebral 
temperature modulations. In asphyxiated infants, the body temperature spontaneously 
falls shortly after the delivery (“behavioural hypothermia") (115). Lowering of the brain 
temperature after perinatal hypoxia-ischaemia has been observed in the newborn infant 
(67). However, there are reports of less efficient selective head cooling in the newborn 
piglet following hypoxia-ischaemia (60) and elevated core temperature in control 
asphyxiated infants in a clinical trial of whole body cooling (9, 60) suggesting the 
difficulty in incorporating the influence of hypoxic-ischaemic stress in the translational 
model. 
Selective head cooling by itself may modulate regional CBF (55, 116) which in turn may 
alter cooling efficacy, because increased CBF can deliver greater amount of heat from 
the trunk. Laptook et al. observed reduced CBF concomitant with lower regional 
temperature in the newborn piglet (55) whereas Walter et al. reported increased 
79 
 
superficial CBF which they conjectured was consequential to vasoparalysis and 
subsequent loss of autoregulation (116). Such CBF re-distribution with selective head 
cooling might be further modified following hypoxia-ischaemia. Future studies have to 
address the regional brain temperature modulation consequential to a range of insult 
severities. 
In addition to the further potential influencing factors of the regional brain temperature 
mentioned above, inter-species anatomical and maturational differences have to be 
taken into account before our results can be translated for application in human 
newborn infants. Compared to the human newborn infant, a normal term piglet has 
lower body weight, smaller brain to body volume ratio, a more mature brain, cranium 
and skin, and no anterior fontanelle (99). Associations between cerebral temperatures 
and the body weight under normothermia, whole body cooling and selective head 
cooling have to be urgently investigated in the human newborn infant using 
non-invasive techniques such as magnetic resonance cerebral temperature imaging 
(117). 
 
3.3.6 Future investigations  
Our results emphasise the importance of robust, cotside, non-invasive regional brain 
temperature measurements in the human infant. Nasopharyngeal temperature could 
provide a proxy for deep brain temperature (8, 57), however, its accuracy has not been 
fully validated. Also, our current study has highlighted the importance of monitoring the 
superficial brain temperature, although this appears to be technically more difficult to 
measure compared to the deep brain temperature. Although not for cotside use, we 
have recently used proton magnetic resonance spectroscopic imaging for cerebral 
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temperature mapping in the newborn piglet (117). Such a non-invasive, in-vivo 
technique could assess the association between regional brain temperatures on the 
body weight in the human infant.  
 
 
3.3.7 Conclusions 
Our study suggests that the body weight is tightly associated with regional brain 
temperatures under therapeutic hypothermia, and particularly, with selective head 
cooling: to avoid excessive cooling, a slightly higher cooling cap temperature may have 
to be considered in a smaller infant. Even with whole body cooling alone, the superficial 
brain temperature may be lower in a lighter infant with potential consequences for 
cortical neuroprotection. Lastly, in the infant who was born with a lower body weight and 
experienced perinatal hypoxic-ischaemic stress, spontaneously cooler superficial brain 
temperature (in spite of systemic normothermia under thermo neutral condition) may 
contribute to the pathophysiological characteristics specific to particular gestational 
ages and body sizes. 
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Chapter 4 
Cerebral temperature, perfusion and metabolism  
under spontaneous body temperature drift in the newborn infant 
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4.1 Methods 
4.1.1 Summary 
This chapter presents the second part of the study. The aim was to prove the hypothesis 
that brain temperatures are dependent on the ambient temperature, body size, cerebral 
blood flow and metabolism, and that brain perfusion and metabolism are positively 
coupled to suffice the tissue energy demand, in the normothermic newborn infant. 
Thirty-two term born and near term born infants who were hospitalised at a tertiary 
neonatal intensive care unit but without critical general condition were studied using 
NIRS and ultrasound cardiography.  
 
- Ethical approval of this study 
This study was conducted under the approval of the ethics committee of Kurume 
University School of Medicine with written informed consent from a parent of each 
participating infant. 
 
4.1.2 Study population 
Thirty-two participating infants without major congenital anomalies (12 males and 20 
females; post-natal age, 21 (17) days; post-conceptional age, 38.3 (2.6) weeks 
corrected age; body weight, 2616 (515) g; indicated as mean (SD)) were recruited from 
the newborn infants who were cared for at the special care unit of a tertiary neonatal 
intensive care unit (Kurume University Hospital, Fukuoka, Japan) between June 2009 
and August 2009. These infants initially required medical care due to preterm birth (n = 
18), transient feeding problem (n = 5), transient neonatal tachypnea (n = 4), gestational 
diabetes mellitus of the mother (n = 3), hypoglycaemia (n = 1) and multiple minor 
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anomalies (n = 1). However, by the time of the study, all infants were stable and healthy 
and were cared for in an open cot with the ambient temperature of approximately 
25-6°C. A cotton blanket was placed over the limbs and the trunk in all infants.  
 
4.1.3 Data collection 
We examined the infants approximately 1 h after feeding when they are either asleep or 
calmly awake. To minimise the technical bias, data collection was conducted in the 
same order, and was completed within 20 min. 
 
4.1.3.1 Temperature measurement 
The data collection was undergone with the infant lying in the supine position (infants 
are not cared for in the prone position in the special care unit). The scalp temperature 
(Tscalp) was measured at the centre of the forehead using a non-contacting infrared 
thermometer (Thermofocus Pro, Technimed, Varese, Italy); temperature measurement 
was repeated three times and the median value was used. To measure the brain 
temperature, two thermal compensation thermistor probes connected to a dual channel 
zero-heat-flow tissue core thermometer (Coretemp, Terumo, Tokyo, Japan) were 
simultaneously applied to the centre of the forehead (Tbrain-15, 15 mm in diameter) and 
the anterior fontanelle (Tbrain-25, 25 mm in diameter); the diameter of the probe 
theoretically corresponds to the depth of the tissue, which the temperature reading 
reflects (118).  
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Figure 4.1: Mechanism of zero-heat flow tissue core thermometer 
 
Diagram depicting the mechanism of zero-heat flux tissue core thermometer. Under 
physiological conditions, the deep brain temperature is slightly higher compared with the 
superficial brain, resulting in a modest thermal gradient within the brain (left). When an 
insulator or an equivalent thermal compensation probe is applied to the scalp surface, the 
heat dissipation is blocked, and the surface temperature starts increasing until it 
equilibrates to the deeper structure, the depth of which depends on the size of the 
insulator.  
 
The temperature measurement was continued until the temperature readings 
equilibrated with the temperature drift of < 0.05oC over a minute for approximately 5 to 
10 min. Finally the Trectal was measured at 3 cm from the anal margin using a digital 
thermometer (C202, Terumo, Tokyo, Japan). The ambient temperature was measured 
beside the infant’s cot using an ambient thermo-hygrometer (605-H1 Mini, Testo, 
Yokohama, Japan). In addition to these absolute temperatures, relative brain 
temperatures to Trectal (Tbrain-25 - Trectal, Tbrain-15 - Trectal and Tscalp - Trectal, respectively) were 
calculated to self-correct for the inter-subject Trectal variation. 
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4.1.3.2 Estimation of cerebral blood flow using ultrasound sonography 
Echocardiographic data were obtained by a same examiner using an ultrasound 
scanner (iE33, Philips, Amsterdam, Netherland) and an 8-13 MHz vector array 
transducer. The SVC flow was measured by an established method (82) using the 
following formula. 
  
SVC flow = Vsvc  HR π (Φsvc2 / 4) 
where  Vsvc = velocity time integral of SVC in cm 
   HR = heart rate per a minute 
Φsvc = mean SVC diameter in cm 
 
Figure 4.2: Estimation of superior vena cava diameter in a representative infant 
 
SVC scanned from the parasternal long axis view as it enters the RA. The maximum and 
minimum internal diameters were measured from an M-mode trace. 
Abbreviations: SVC, superior vena cava. RA, right atrium. Max, maximum. Min, minimum. 
Ant, anterior. Post, posterior. Sup, superior. Inf, inferior. 
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Figure 4.3: Measurement of velocity time integral for the superior vena cava flow 
in a representative infant 
 
 
Colour Doppler mapping (red area) highlighting the flow up the SVC and into the right 
atrium (left panel) and SVC flow measured from the subcostal view (right panel). The SVC 
flow pattern is pulsatile with two peaks: the first associated with ventricular systole and 
the other with early ventricular diastole. Frequently, short periods of reverse flow 
associated with atrial systole is observed. The mean velocity of blood flow is calculated 
from the integral of the Doppler velocity tracings. 
Abbreviation: SVC, superior vena cava. 
 
SVC flow was corrected to 100 g brain mass (rSVC flow); the brain weight was 
estimated from the head circumference using an equation proposed by Dobbing and 
Sands (119). 
 
Brain weight = HC3/100 - 3000/2HC 
where  HC = head circumference in cm 
 
The presence (and the diameter) of the patent ductus arteriosus was also assessed.   
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4.1.3.3 NIRS data acquisition  
Simultaneously with the echocardiographic examination, another examiner underwent 
NIRS temporal profile data acquisition using a time-resolved NIRS system (TRS-10, 
Hamamatsu Photonics, Hamamatsu, Japan) and a probe fixed to the infant’s forehead 
for the estimation of absolute cerebral tissue oxy-, deoxy- and total haemoglobin (Hb) 
concentrations.  
This system employs three pulsed laser diodes with different wavelengths (760 nm, 794 
nm and 836 nm) as the light source, which generates light pulses with pulse width of 
around 100 ps, pulse rate of 5 MHz and an average power of 30 μW at each wavelength 
(see (120) for the detail of the system). A photomultiplier tube (H7422P-50MOD, 
Hamamatsu Photonics, Japan) for high sensitive detection and a signal processing 
circuit based on a time-correlated single photon counting method for high-speed 
time-resolved measurements are used. A single GI-mode optical fibre with a numerical 
aperture of 0.25 and a core diameter of 200 μm is used for light incident to samples. A 
SI-mode optical bundle fibre with a numerical aperture of 0.26 and a bundle diameter of 
3 mm is used to collect diffuse light from the samples. Prisms are mounted at the tip of 
each fibre respectively, and the direction of the light incident and collection is vertically 
bent along the fibre.  
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Figure 4.4: Mechanism of time resolved near-infrared spectroscopy 
 
Diagram depicting the difference between continuous wave NIRS and time resolved NIRS. 
As the latter system can measure the time between the release of a photon and its arrival 
at the receiver, the path length of the photon can be calculated, which allows the 
estimation of the absolute haemoglobin concentration within tissue.  
Abbreviation: NIRS, near infrared spectroscopy. 
 
A rubber attachment is used for shielding the stray light except the incident light and 
fixing the incident and collection fibres on the surface of samples with the distance of 30 
mm each other. The instrumental response of the system is measured by placing the 
incident fibre opposite the collection fibre with a neutral density filter between them. 
Applying the solution of photon diffusion equation for semi-infinite homogeneous media 
with zero boundary condition in reflectance mode, the values of the reduced scattering 
coefficients and the absorption coefficients are obtained using the non-linear 
least-square method considering the instrumental responses. Refractive index in the 
samples is assumed to be 1.37.  
In this 700 nm to 900 nm wave length range, the light absorption  at wave length λ 
in sample can be expressed approximately by the following equation, 
λµ ,a
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where, is the molar extinction coefficient of substance m at wave length λ, is 
the concentration of substance m and the water absorption in sample. After the 
subtracting the water absorption from , assuming that the volume fraction of the 
water content is constant, the concentrations of HbO2 and Hb can be determined by 
solving the simultaneous equations at three wavelengths using the least-square method. 
Ten-second data acquisition was repeated five times by repositioning the probe each 
time to give mean values. The data quality was inspected retrospectively for their fitting 
into the photon diffusion equation and reproducibility before/after repositioning. 
The tissue oxygenation index (TOI) and cerebral blood volume (CBV) were further 
calculated using the following formulas. 
 
TOI = [oxy-Hb] / ([oxy-Hb] + [deoxy-Hb]  
 
CBV = ([oxy-Hb]+[deoxy-Hb])MWHB10-6 / (10tHb10-2Dt) 
 
where  [ ] indicates Hb concentrations in μM 
MWHb = molecular weight of Hb (64,500) 
tHb = blood Hb concentration (g/dL) 
Dt = brain tissue density (1.05g/mL) 
 
λλλλ µεεµ ,,,,, 22222 OHaHbOHbOHbOHbOa CC ++=
λε ,m mC
λµ ,a
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SpO2 values were recorded at the beginning, in the middle and at the end of the NIRS 
data acquisition using a pulse oximeter (Rad-8, Masimo, Irvine, CA, U.S.A.) attached to 
the infant’s right hand; the mean value was used for the analysis. Cerebral venous 
oxygen saturation (SvO2) was estimated using the method proposed by Tichauer and 
colleagues (121), which assumed that the relative contribution of venous and arterial 
blood to the total blood volume in the brain is approximately 3:1 (121, 122). 
 
SvO2 = 4/3  TOI – 1/3  SpO2  
 
As surrogate markers for cerebral metabolism, we also calculated the fractional oxygen 
extraction (FOE) and the cerebral metabolic rate index (CMRO2 index) using following 
equations; we used rSVC flow as a surrogate marker of CBF. Because most 
participating infants were well saturated without additional oxygen, CBF measurement 
using the oxygen bolus technique was inapplicable. It was based on the assumption 
that the fraction of the total brain perfusion to the total SVC flow is similar or of limited 
variations between infants.  
 
FOE = (SpO2 - SvO2) / SpO2 
CMRO2 index = 1.34  tHb  rSVC flow  (SpO2 – SvO2) 
where  1.34 (mL) = oxygen-binding capacity of Hb per gram 
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4.1.3.4 Clinical independent variables for cerebral temperature, perfusion 
and metabolism 
Clinical information, such as the gestational age, body weight, post-natal age, head 
circumference at the time of the study, and the blood Hb concentration assessed within 
3 days of the study, was obtained from the patient’s record.  
 
4.1.4 Data analysis 
Absolute temperatures were compared between different sites using the paired t-test. 
Relationships between the absolute/relative temperatures, cerebral metabolism and 
perfusion, and other clinical and physiological variables were assessed using univariate 
linear regression analysis. For multivariate models, which explain the absolute and 
relative temperatures, we assigned up to 3 independent variables based on (i) our 
hypothesis that body/brain temperatures are determined by cerebral perfusion and 
metabolism (CMRO2 index not included due to significant collinearity with the rSVC 
flow), and (ii) the result of univariate analysis (independent variables with p-values < 
0.05 considered).  The results from the statistical analysis were presented without 
correction for multiple comparisons because of the exploratory nature of the study. 
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4.2 Results 
Values are shown as mean (SD) unless otherwise noted. Data from 3 infants were 
excluded because of poor fitting of NIRS data into the photon diffusion equation. 
 
4.2.1 Summary 
In this chapter, the results of the in-vivo measurement of the body/brain temperature, 
cerebral perfusion and metabolism are presented. In healthy newborn infants, brain 
temperature was associated with the ambient temperature and cerebral perfusion, but 
not the body weight; there was a trend that the relationship between cerebral perfusion 
and brain temperatures was more prominent towards the superficial brain. The rSVC 
temperatures were not associated with FOE and CMRO2 index.  
 
4.2.2 Temperature profile 
Trectal (37.0 (0.2) °C) was the highest of all temperature monitoring sites, which was 
followed by Tbrain-25 (36.7(0.2) °C), Tbrain-15 (36.2(0.2) °C) and Tscalp (34.7 (0.3) °C) (see 
table 4.1); significant differences were observed between Trectal and Tbrain-25, Tbrain-25 and 
Tbrain-15, and Tbrain-15 and Tscalp respectively (all p < 0.001). A higher Trectal was associated 
with a greater post-natal age, body weight and brain weight (all p < 0.01).  
 
4.2.3 Echocardiographic observations 
The ductus arteriosus was patent in 2 infants; the flow pattern was restrictive with the 
diameter of less than 1.0 mm in both cases. SVC flow relative to the body weight was 
93.1 (35.6) mL/kg/min; no infant showedcritically low SVC flow less than 40 mL/kg/min 
(123). The rSVC flow was not associated with any background clinical variables. 
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4.2.4 Haemoglobin data profile and its derivative indices 
A greater post-natal age was associated with lower blood Hb concentration (p < 0.001), 
cerebral oxy-Hb concentration (p < 0.01), TOI (p < 0.01), and CMRO2 index (p < 0.05), 
and greater CBV and FOE (both p < 0.01). A greater post-conceptional age was only 
associated with higher deoxy-Hb concentration (p < 0.05). A greater body weight 
showed weak correlations with greater deoxy-Hb concentration, CBV and FOE, and 
lower TOI and CMRO2 index (allh p < 0.05), whereas a greater brain weight was 
associated with greater CBV and FOE (both p < 0.05), and lower CMRO2 index (p < 
0.01). 
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Table 4.1: Data profile and their dependence on the clinical background variables 
 Mean SD Pearson product moment correlation coefficient 
   post-natal age post-conceptional age body weight brain weight 
Clinical background variables           
post-natal age (days) 21.0 17.8 - - - - - - - - 
post-conceptional age (weeks) 38.1 2.6 - - - - - - - - 
body weight (g) 2556.0 503.3 - - - - - - - - 
brain weight (mL) 323.5 55.5 - - - - - - - - 
Temperature measures (°C)           
ambient temperature  25.7 0.9 -0.12  0.03  -0.22  -0.14  
Trectal  37.0 0.2 0.56 ** 0.17  0.53 ** 0.52 ** 
Tbrain-25  36.7 0.2 0.33  0.35  0.16  0.16  
Tbrain-15  36.2 0.2 0.31  0.23  0.06  0.25  
Tscalp  34.7 0.3 0.37  0.16  0.03  0.21  
Tbrain-25 - Trectal  -0.3 0.2 -0.23  0.20  -0.38 * -0.37  
Tbrain-15 - Trectal  -0.8 0.3 -0.08  0.13  -0.35  -0.12  
Tscalp - Trectal  -2.3 0.3 -0.01  0.05  -0.37  -0.15  
Hb concentration, blood flow & derivatives 
blood Hb (g/dL) 14.0 3.6 -0.75 *** 0.01  -0.15  -0.30  
rSVC flow (mL/100g/min) 72.7 26.1 -0.20  0.01  -0.22  -0.23  
oxy-Hb (μM) 34.7 6.4 -0.61 *** 0.22  0.13  -0.07  
deoxy-Hb (μM) 18.2 2.7 -0.28  0.43 * 0.46 * 0.20  
TOI  0.65 0.03 -0.56 ** -0.20  -0.38 * -0.36  
CBV (mL/100g) 2.4 0.5 0.62 *** 0.27  0.41 * 0.42 * 
 FOE  0.45 0.05 0.60 ** 0.15  0.40 * 0.40 * 
CMRO2 index (mLO2/100g/min) 5.7 2.1 -0.46 * -0.09  -0.38 * -0.56 ** 
* p < 0.05, ** p < 0.01 and *** p < 0.001 
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Abbreviations: SD, standard deviation. Trectal, rectal temperature. Tbrain-25 and Tbrain-15, brain temperatures measured using a zero-heat flux 
thermometer with probe diameters of 25mm and 15mm respectively. Tscalp, forehead scalp skin temperature measured using 
non-contacting infrared thermometer. Hb, haemoglobin. rSVC flow, relative blood flow of the superior vena-cava. TOI, tissue oxygenation 
index. CBV, cerebral blood volume. FOE, fractional oxygen extraction. CMRO2, cerebral metabolic rate of oxygen. 
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4.2.5 Associations between cerebral temperature, perfusion and 
metabolism 
4.2.5.1 Univariate analysis  
No significant association was observed between the rSVC flow and CBV. The CMRO2 
was positively correlated with the rSVC flow and was negatively correlated with CBV (p 
< 0.001 and p < 0.05, respectively) (Fig. 4.5). FOE was not associated with the rSVC 
flow and CBV. Linear correlations were observed between Trectal, Tbrain-25, Tbrain-15 and 
Tscalp (Table 4.2 (a)). These temperature values were independent from the ambient 
temperature. A lower Trectal was associated with higher TOI, smaller CBV and smaller 
FOE (all p < 0.01). A lower Tscalp was associated with lower rSVC flow and smaller CBV 
(both p < 0.05).  Higher Tbrain-25 – Trectal, but not Tbrain-15 – Trectal and Tscalp – Trectal, was 
correlated with lower Trectal (Table 4.2 (b)). Greater Tbrain-25 – Trectal, Tbrain-15 – Trectal and 
Tscalp – Trectal were associated with the higher ambient temperature (all p <0.05, Fig. 4.6 
(A)). Greater Tbrain-15 – Trectal and Tscalp – Trectal were associated with a higher rSVC flow (p 
<0.05 and p <0.01, respectively; Fig. 4.6 (B)). 
 
4.2.5.2 Multivariate analysis 
A higher Trectal was associated with greater FOE and CBV (both p < 0.05). A higher 
Tbrain-25 and Tbrain-15 were associated with a greater rSVC flow (both p < 0.05). A higher 
Tscalp was associated with a greater rSVC flow and CBV (both p < 0.01).  Greater 
Tbrain-15 – Trectal and Tscalp – Trectal were associated with the higher ambient temperature 
(both p < 0.05). Greater Tscalp – Trectal was associated with a higher rSVC flow (p < 0.01). 
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Figure 4.5: Relationship between cerebral metabolism and haemodynamics 
 
The CMRO2 index was positively correlated with the rSVC flow (A) and was negatively 
correlated with CBV (B) (p < 0.001 and p < 0.05, respectively).  
Regression lines are from univariate analysis.  
Abbreviations: CMRO2, cerebral metabolic rate of oxygen. CBV, cerebral blood volume. 
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Figure 4.6: Independent variables associated with relative brain temperatures 
 
(A): Greater Tbrain-25 – Trectal (), Tbrain-15 – Trectal (Δ) and Tscalp – Trectal (○) were associated 
with the lower ambient temperature (all p <0.05). (B): Greater Tbrain-15 – Trectal and Tscalp – 
Trectal were associated with a higher rSVC flow (p < 0.05 and p < 0.01, respectively). R2 
values and regression lines were showed same colours with markers of relative brain 
temperatures, respectively: Regression lines are from univariate analysis with p < 0.05.  
Abbreviations: rSVC flow, relative flow of the superior vena cava. Tscalp, scalp temperature. 
Trectal, rectal temperature. Tbrain-15 and Tbrain-25, brain temperatures obtained using 
zero-heat-flow tissue-core thermometer at the forehead and the anterior fontanelle, 
respectively.
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Table 4.2: Relationships between cerebral perfusion, metabolism and temperatures 
(a) Absolute temperature 
Univariate analysis Pearson product moment correlation coefficient 
Variables Trectal  Tbrain-25  Tbrain-15  Tscalp  
 Temperature measures         
 ambient temperature -0.19   0.17   0.28   0.26   
   Trectal -  0.54  ** 0.51  ** 0.46  * 
   Tbrain-25 -  -  0.65  *** 0.67  *** 
   Tbrain-15 -  -  -  0.81  *** 
 Hb, blood flow and derivatives 
 
 
 
 
 
 
 
 
 rSVC flow -0.05   0.27   0.30   0.47  * 
 TOI -0.50  ** -0.34   -0.14   -0.16   
 CBV 0.52  ** 0.31   0.21   0.39  * 
 FOE 0.51 ** 0.29  0.17  0.14  
 CMRO2 index -0.34   -0.05   -0.09   -0.05   
Multivariate analysis Standardised partial regression coefficient 
Variables Trectal  Tbrain-25  Tbrain-15  Tscalp  
 rSVC flow 0.14   0.40 * 0.40 * 0.59 ** 
 CBV 0.43  * 0.30  0.22  0.45 ** 
 FOE 0.44  * 0.32  0.21  0.17  
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(b) Relative brain temperature to Trectal 
Univariate analysis Pearson product moment correlation coefficient 
Variables Tbrain-25 - Trectal  Tbrain-15 - Trectal  Tscalp - Trectal  
 Temperature measures       
 ambient temperature 0.38 * 0.47  * 0.42  * 
   Trectal -0.46 * -0.20  -0.23  
   Tbrain-25 0.50  0.33  0.34  
   Tbrain-15 0.17  0.75 *** 0.51 ** 
 Tscalp 0.23  0.56 ** 0.76 *** 
 Hb, blood flow and derivatives 
 
 
 
 
 
 
 rSVC flow 0.34   0.38  * 0.55  ** 
 TOI 0.16   0.23   0.20   
 CBV -0.21   -0.16   0.05   
 FOE -0.22  -0.21  -0.23  
 CMRO2 index 0.31   0.18   0.21   
Multivariate analysis Standardised partial regression coefficient 
Variables Tbrain-25 - Trectal  Tbrain-15 - Trectal  Tscalp - Trectal  
 ambient temperature 0.30  0.40 * 0.36 * 
 rSVC flow 0.25  0.29  0.50 ** 
 CBV -0.08  -0.05  -0.09  
 FOE -0.08  -0.01  0.24  
*p < 0.05, **p < 0.01 and ***p < 0.001 
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Abbreviations: Trectal, rectal temperature. Tbrain-25 and Tbrain-15, brain temperatures measured using a zero-heat flux thermometer with probe 
diameters of 25mm and 15mm respectively. Tscalp, forehead scalp skin temperature measured using non-contacting infrared thermometer. 
Hb, haemoglobin. rSVC flow, relative blood flow of the superior vena-cava. TOI, tissue oxygenation index. CBV, cerebral blood volume. 
CMRO2, cerebral metabolic rate of oxygen. 
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4.3 Brief Discussion  
4.3.1 Summary 
Our hypothesis which was based on the findings in the experimental setting was refuted. 
Unlike anaesthetised animals undergoing temperature monitoring in a relatively cooler 
environment, brain temperatures in the newborn infants were associated with ambient 
temperature, but not body size. Brain temperature was associated with cerebral 
perfusion, particularly in the superficial brain; although brain perfusion and metabolism 
were positively coupled between each other, the variation in cerebral metabolism had 
no significant impact on regional brain temperatures. Thus far, CBF has been 
predominantly linked with heat removal from the deep brain tissue. However, our data 
suggest that CBF may have an alternative role to deliver heat to the superficial brain. 
The findings of this study are discussed in this chapter. 
 
- Key Findings from this Study 
We were able to obtain information about cerebral metabolism and perfusion in healthy 
newborn infants using two non-invasive cotside techniques: NIRS and 
echocardiography. In these healthy infants, cerebral perfusion and ambient temperature 
were significantly associated with brain temperatures. Cerebral perfusion was most 
closely associated with superficial, nor deeper brain temperatures. A cooler ambient 
temperature was associated with a greater temperature gradient between the scalp 
surface and the body core. Further studies are required to assess the influence of 
cerebral metabolism and perfusion to regional brain temperatures in low-cardiac output 
conditions, fever and with therapeutic hypothermia.  
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- What is already known and what our study adds 
What is already known: 
 Bedside monitoring of cerebral metabolism and perfusion has been established 
using NIRS and tracers such as oxygen and indocyanine green. 
 In uninjured brain, tissue perfusion is tightly adjusted according to the change in 
cerebral energy metabolism to suffice the tissue demand for energy substrates. 
 Brain temperature is determined by the balance between cerebral metabolism, CBF 
and heat dissipation through the scalp. 
 In newborn preclinical and clinical studies, ambient temperature and humidity, 
maturation of skin, and body size have been recognised as important influencing 
factors to the body/brain temperatures. 
 
What our study adds: 
  Using NIRS and echocardiography, but not tracers, cerebral metabolism and 
perfusion were estimated in the newborn infant.  
  In healthy newborn infants under normal ambient conditions, a greater rSVC flow 
was associated with higher superficial brain temperatures, suggesting a role of 
cerebral perfusion to deliver heat to the superficial brain. 
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4.3.2 Non-invasive, bedside monitoring of cerebral metabolism and 
perfusion 
Recent advances in biophysical probes provided a range of useful techniques to 
monitor the cerebral oxygen metabolism and perfusion. As for the use in the newborn 
infant, NIRS, which is available at the cotside, has an outstanding advantage to other 
methods, such as MRI, magnetic resonance spectroscopy and positron-emission 
computed tomography. However, NIRS still requires clinically unnecessary tracers in 
measuring CBF, which may have restricted the extensive use of this technique. In our 
current study, by combining NIRS and echocardiography, we were able to obtain 
surrogate markers of CMRO2 and CBF without using tracers.  
Although the obtained data showed relevant correlations with other physiological 
variables, it has to be noted that our method is based on several assumptions. For 
example, the fraction of CBF relative to SVC flow was assumed to be similar between 
subjects. According to a study in newborn infants, which used indocyanine green pulse 
dye densitometry, the relationship between left ventricular output (LVO) and CBF was 
estimated as: CBF = 0.03･LVO + 8.71 (124). Given that SVC flow is approximately 52% 
of LVO in term infants (82), CBF in our study population is estimated to be 12.9 (1.5) 
mL/(100g brain weight)/min, which corresponds to the reported CBF values in newborn 
infants. However, unlike the tracer bolus technique which gives the regional CBF value, 
our method can only provide the surrogate for the global CBF, suggesting its limitation 
under pathologically altered CBF distributions (125). 
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Figure 4.7: Correlation between cardiac output and cerebral blood flow 
 
Cerebral blood flow was measured by multichannel near infrared spectroscopy and pulse 
dye densitometry using indocyanine green in 19 newborn infants. The linear regression 
line is described by CBF = 0.03 CO + 8.71, with a correlation coefficient of 0.70 and p = 
0.002.  
From “Cerebral distribution of cardiac output in newborn infants.” by Kusaka T, Okubo K, 
Nagano K, Isobe K, Itoh S. Arch Dis Child Fetal Neonatal Ed. 2005 Jan;90(1):F77-8. 
 
Our data suggested post-natal decrease in oxy-Hb and TOI, and increase in CBV and 
FOE, highlighting the influence of growth-related increase in cerebral venous blood pool 
and the post-natal progress in anaemia (126).  
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Figure 4.8: Cerebral haemodynamic change after birth 
 
From top to bottom: HbT, CBV, and StO2 as a function of age measured in the frontal 
region in all infants. The straight lines are linear regressions from 0 to 6, 12 to 50, and 0 to 
50 weeks. Open circles correspond to premature babies. Cyan circles are results for a 
baby measured longitudinally 20 times from 0 to 11 months. Y and R2 for each regression 
line are reported on the graphs with the same color as the regression line.  
From “Assessment of infant brain development with frequency-domain near-infrared 
spectroscopy.” by Franceschini MA, Thaker S, Themelis G, Krishnamoorthy KK, Bortfeld 
H, Diamond SG, Boas DA, Arvin K, Grant PE. Pediatr Res. 2007 May;61(5Pt1):546-51. 
Abbreviations: HbT, total-haemoglobin concentration. CBV, cerebral blood volume. StO2, 
tissue oxygen saturation. 
 
In contrast, the CMRO2 index showed a weak negative association with the postnatal 
age. Although previous studies have demonstrated gradual increases in CMRO2 with 
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age (79), its timing and rate of change varied considerably between studies, suggesting 
that the range of the post-natal age for our subjects might be too narrow to demonstrate 
the growth-related change in cerebral metabolism. 
In our current study, we used time-resolved NIRS, which instantly provides absolute Hb 
concentrations and CBV. Several studies have proposed the estimation of CBF from 
CBV using a formula: (CBV/CBV0) = (CBF/CBF0)G, where G is the Grub’s exponent, and 
CBV0 and CBF0 are baseline values. In our current study, we did not observe any 
association between the rSVC flow and CBV, presumably because this technique has 
only been validated for dynamic intra-subject CBF changes induced by substantial 
hypercapnia and hypocapnia (79, 127, 128). Future studies need to investigate whether 
subtle intra-subject differences in CBF can be extrapolated from CBV.  
 
4.3.3 Brain temperature and monitoring 
Non-invasive brain temperature monitoring using the zero-heat-flux method was initially 
proposed by Fox and Solman (129), and it was later introduced to the newborn infant 
(67, 95). Of various sizes and types of zero-heat-flux thermometers, Matsukawa and 
colleagues validated the same system with ours, but with a full-size sensor element 
(43mm in diameter), and reported that the temperature reflected the tissue of 18-38mm 
from the surface (96). Because the full-size probe was too large for the infant’s forehead, 
we used small-sized probes with the diameters of 15 mm and 25 mm, expecting to 
monitor the temperature of the superficial brain tissue with approximately 10 to 20mm 
depths rather than the core structure. This assumption was relevant to the finding that 
the temperature showed gradual reduction from Trectal to Tbrain-25, Tbrain-15, and then, Tscalp, 
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as the core brain temperature of the newborn species is higher than other core body 
temperatures (67, 130).  
 
4.3.4 Associations between body size, ambient temperature and 
brain/body temperatures 
Previously, we found that a smaller body size was associated with a cooler brain 
temperature in a newborn piglet model (see chapter 2). Based on this observation, we 
hypothesised that a similar relationship between brain temperatures and the body size 
are observed in the newborn infant. However, this hypothesis was refuted in the current 
study, which recruited healthy newborn infants; no relationship was observed between 
brain temperatures and the body weight. In the previous experimental study, the rectal 
temperature of the piglet was tightly controlled to the target level; in addition, animals 
were anaesthetised throughout the experiment, which is likely to suppress the 
spontaneous temperature control and variation in the body temperature. In contrast, in 
the current clinical study, there was a greater variation in rectal temperature, which 
showed positive association with the body weight of infants. Given the positive 
correlation between brain temperatures and rectal temperature, the lack of relationships 
between brain temperatures and the body size might be explained by the greater 
variations in subjects’ background factors (e.g. ambient temperature, gestational age 
and postnatal age) and their interactions between each other. For example, more 
mature (and hence generally larger) infants respond to both excessively warm and cold 
environments more efficiently by altering metabolic thermogenesis, vasomotor 
regulation and sweating, thus compromising the association between regional brain 
temperatures and other variables (69, 131, 132). In addition, unlike the experimental 
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model in the previous study, infants in the current study were insulated by cotton clothes 
and blanket, which may cause scalp-surface-predominant heat exchange with the 
ambient air. 
 
4.3.5 Associations between metabolism, perfusion and brain temperature 
To promote intact survival following high-risk birth, it is essential to maintain cerebral 
perfusion appropriate to its demand, because of the little storage of energy substrates 
within the brain (133). Recent clinical studies in asphyxiated newborn infants suggest 
that mild to moderate therapeutic hypothermia is neuroprotective, whereas even modest 
hyperthermia is deleterious (52, 134). However, thus far, few studies have addressed 
the associations between the body/brain temperature, metabolism and perfusion in the 
newborn infant. Based on a small number of clinical cases, it was reported that newborn 
infants with diminished cerebral metabolism due to the underlying brain pathology, such 
as hydrocephalus and cerebral asphyxia, have low brain temperatures, whereas infants 
with cerebral hypo-perfusion due to hypo-plastic left heart syndrome have relatively 
higher brain temperatures (67). In addition to the local temperature regulation in the 
brain, systemic thermogenic response to cold stress has been well described in the 
newborn species (135, 136). Referring to these findings, we initially estimated that, in 
healthy newborn infants, spontaneous body/brain temperature reduction may be 
observed in association with reduced systemic/cerebral metabolism.  
Contrary to our estimation, associations between the cerebral metabolism and the brain 
temperature were not recognised, which might be explained by the limited effect of 
cerebral metabolism to the brain temperature under a physiological condition (137). 
Instead, the rSVC flow showed the most prominent association with the brain 
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temperature in our subjects: the greater the cerebral perfusion was, the higher the brain 
temperature was. This finding may be initially counterintuitive, because the blood 
temperature is higher in the jugular vein than in the carotid artery (138), and hence, 
cerebral perfusion generally contributes to the heat removal from the brain tissue (67, 
68, 137). However, the superficial brain is spontaneously cooled by the environment, 
and is cooler than the arterial blood, suggesting that, under a physiological condition, an 
increase in CBF may lead to simultaneous increase in the superficial brain temperature 
and decrease in the deep brain temperature. A similar phenomenon, or “the 
temperature-shielding effect of blood flow”, has been suggested from a mathematical 
model and in a small animal model, where CBF was supposed to protect the brain from 
“extracranial cold” to penetrate deep brain structures (68). Although we did not monitor 
the core brain temperature, the positive association between brain temperatures and 
rSVC flow became weaker towards deep brain structures.  
Further investigations are required to assess the influence of cerebral metabolism and 
perfusion to regional brain temperature by incorporating a range of clinical conditions, 
such as low-cardiac output, high fever, neonatal encephalopathy, therapeutic 
hypothermia, and sedation, which may determine the optimal therapeutic temperature 
distribution within the injured brain. 
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Figure 4.9: Loss of hypothermic neuroprotection in unsedated newborn piglets  
 
Pathology scores (and interquartile range) were invariant between cooled subjects (24 h 
to 35°C followed by 48 h of normothermia) and normothermic subjects (Trectal at 39°C for 
72 h). It was speculated that the stress of shivering and feeling cold interfered with the 
previously shown neuroprotective effect of hypothermia.  
From “Twenty-four hours of mild hypothermia in unsedated newborn pigs starting after a 
severe global hypoxic-ischemic insult is not neuroprotective.” by Thoresen M, Satas S, 
Løberg EM, Whitelaw A, Acolet D, Lindgren C, Penrice J, Robertson N, Haug E, Steen PA. 
Pediatr Res. 2001 Sep;50(3):405-11. 
 
It was also interesting that Tscalp, which was measured using a non-contacting infrared 
thermometer, showed relatively higher correlations with rSVC flow compared with other 
brain temperatures. This observation may merely reflect a greater bias to the indirect 
temperature estimation using thermo-compensation probes compared to the direct 
scalp-skin temperature measurement using infrared light. However, given that the 
perfusion of the cortical grey matter is much higher than that of subcortical white matter 
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(139), Tscalp might more precisely reflect subtle changes in the blood flow and 
metabolism in the superficial brain structure compared to other methods. 
 
4.3.6 Limitation of the study 
Our current study is a cross-sectional observational study, and hence, our speculations 
derived from inter-subject correlations of variables have to be confirmed in future 
studies, which incorporate repeated measures within subjects. As previously discussed, 
our non-invasive monitoring technique of cerebral metabolism and perfusion is based 
on the assumptions that haemodynamic information derived from NIRS is 
predominantly obtained from intra-cerebral blood flow, and that, several factors, such as 
the cerebral arterial/venous blood contribution and regional CBF distribution, are 
consistent or of limited variation between subjects. In addition, our method estimated 
global CBF, which would not be suitable to identify spatially heterogeneous CBF 
distributions (125). Hence, our non-invasive monitoring method might be less accurate 
compared to direct, invasive monitoring modalities. Because these variables were 
compared with body/brain temperatures, which had a limited variation range between 
34.1 and 37.4°C, caution against false-positive/negative observations is required.  
Newly developed techniques such as the one we describe and near-infrared diffuse 
correlation spectroscopy, which allow the estimation of local CBF without tracers need 
validation (140). In addition, we were unable to study newborn infants shortly after birth; 
during this time more dynamic changes in thermo-regulative variables might be 
observed. These limitations have to be noted in interpreting our current findings to the 
clinical practice.  
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4.3.7 Future investigations 
Considering the rapid increase in the number of newborn infants who undergo 
therapeutic hypothermia as a standard of care for neonatal encephalopathy (141), it is 
essential to optimise the detailed protocol of this treatment to increase the number of 
responders to the treatment. Findings from our previous preclinical study suggested that, 
even under therapeutic hypothermia, which used a solid cooling protocol, the 
temperature value delivered to the local brain tissue is highly heterogeneous according 
to physiological background factors such as the body weight (see chapter 2). Although 
we observed significant relationships between regional brain temperatures, ambient 
temperature and cerebral perfusion, we did not demonstrate a relationship between 
brain temperature and body size. This differs to our experimental study in anaesthetised 
piglets. Future studies need to assess the relationship between the body size, cerebral 
metabolism/perfusion and regional brain temperatures by including larger dynamic 
changes in intrinsic and extrinsic temperature regulation, such in newborn infants 
shortly after birth and those undergoing therapeutic hypothermia. 
 
In addition to the variation in response to cooling, inconsistency in the cooling 
procedures may further increase the range in the regional brain temperature and the 
corresponding level of tissue protection. Currently, therapeutic hypothermia for 
asphyxiated newborn infants are generally conducted using the protocols designed for 
the large scale clinical studies (142), which is compliant to the recommendation in 2010 
Consensus on Science with Treatment Recommendations. However, the detail of 
cooling modalities and supportive treatments, such as the temperature of the cooling 
cap and the type of sedation provided, are highly heterogeneous between institutions 
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(143). To yield the optimal brain protection by therapeutic hypothermia, especially when 
selective head cooling is used, temperatures for the cooling device may have to be 
adjusted according to systemic/cerebral perfusion and metabolism. Future studies have 
to address exact relationships between clinical background factors, cooling modalities, 
regional brain temperatures, brain perfusion and metabolism, subsequent protection 
level of the brain tissue, and the long term neurodevelopmental functioning. 
Translational large animal models and bridging biomarkers such as magnetic resonance 
spectroscopic imaging and NIRS are likely to play important roles in providing swift feed 
back to the clinical practice. 
 
4.3.8 Conclusions 
Cerebral oxygen metabolism and perfusion were monitored in newborn infants using 
two non-invasive techniques. In these healthy infants, cerebral perfusion and ambient 
temperature showed significant correlation with brain temperatures. Cerebral perfusion 
was most closely associated with superficial, nor deep brain temperatures. Further 
studies are required to assess the influence of cerebral metabolism and perfusion to 
regional brain temperature in low-cardiac output conditions, fever and with therapeutic 
hypothermia. 
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Chapter 5 
Induction and maintenance of therapeutic hypothermia using  
either commercial water bottles or a “phase changing material” mattress  
to facilitate safe and efficient pre-hospital cooling     
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5.1 Methods 
5.1.1 Summary 
This chapter presents the third part of the study. The aim was to prove the hypothesis 
that a temporal, non-electronic device provides safe and stable cooling by the time of 
admission to a tertiary cooling centre. To assess the utility of two low-tech, low-cost 
cooling devices, eleven anaesthetised newborn piglets were observed between 2-26 h 
after hypoxia-ischaemia with the target Trectal of 33 to 34oC.  
 
- Ethical approval of this study 
This study was conducted under UK Home Office licence in accordance with UK 
guidelines. 
 
5.1.2 Subject preparation 
Eleven male Large-White piglets (mean body weight (SD), 1.73 (0.17) kg) were studied 
within 24 h of birth. 
 
5.1.3 Anaesthesia and surgical procedures 
Animals were surgically prepared under general anaesthesia, and received intensive life 
support and continuous physiological monitoring including arterial oxygen saturation 
throughout the experimental procedure as previously described (see chapter 3.1.3). 
Briefly, general anaesthesia was induced using isoflurane (5% through a facial mask 
during the insertion of the tracheostomy tube, ~3% during surgery and 1.5-2.5% 
thereafter). Animals were mechanically ventilated through the tracheostomy tube to 
maintain normal PaCO2 and PaO2. Maintenance fluid, continuous morphine infusion 
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and antibiotics were given via the umbilical venous catheter. Heart rate, blood pressure, 
and blood gases were monitored via an umbilical arterial catheter. Both common carotid 
arteries were encircled by vascular occluders (OC2A, In Vivo Metric, Healdsburg, CA, 
U.S.A.). The aEEG (BRM2 Brain Monitor, Brainz Instrument, Manukau, New Zealand) 
was continuously monitored using 2 each right and left (1.5 cm lateral from the sagittal 
suture) recording electrodes (1 cm and 3.5 cm posterior from the bregma) and a 
reference electrode. Following surgery, piglets were positioned prone on an open 
incubator covered with a polytrianfoam mattress. The Trectal was monitored (Arbo 
N44-91, Kendall, Powell, TN, U.S.A.) at 6 cm from the anal sphincter, which was initially 
maintained normothermic for the newborn piglet (38.5 ± 0.5°C) using cotton blankets 
over the dorsal trunk. 
 
5.1.4 Transient hypoxia-ischaemia and assessment of insult severity 
After stable normothermia was achieved (defined as a Trectal fluctuation < 0.2°C for at 
least 30 min without modifying blanket use), piglets were exposed to transient 
hypoxia-ischaemia before the initiation of cooling, because perinatal hypoxia-ischaemia 
is known to alter CBF and cerebral metabolism (14, 144), which may further affect 
regional brain temperatures. The fraction of inspired oxygen (FiO2) was reduced to 12% 
and simultaneously the carotid artery occluders were inflated. A fixed insult protocol was 
used for induction (10 min with FiO2 12%) and maintenance (15 min with FiO2 16%); this 
was based on the average induction time and the total insult duration required to induce 
70% NTP deprivation and moderate cerebral injury with 30-40% cortical neuronal death 
at 48 h in our previous study performed using phosphorous-31 magnetic resonance 
spectroscopy (62). After this period resuscitation was commenced by deflating the 
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balloon occluders and increasing FiO2; normal arterial oxygen saturation was 
maintained thereafter. The insult severity and the short term cerebral functional 
outcome were assessed using the upper and lower margin of aEEG at the 
commencement of and 2, 14 and 26 h after resuscitation and at the completion of 
rewarming. 
 
5.1.5 Preparation of cooling devices 
Piglets were randomly assigned to 2 groups: (i) therapeutic hypothermia using a PCM 
mattress (n = 6, body weight 1719 (163) g) or (ii) therapeutic hypothermia using water 
bottles (n = 5, 1749 (189) g). For the PCM mattress, 90 g of PCM with a melting point of 
32°C (Climsel 32, Climator, Skövde, Sweden: latent-heat 54 Wh/kg, specific-heat 1 
Wh/kg/°C) was packaged in a laminate pack. Sixteen PCM packs were built into 2 
layers of 4 × 2 PCM sheets, with the upper surface covered by a thermal conductor (a 
plastic bag filled with 450 ml water, See Fig. 5.1 (A)). The mattress (total-weight 1940 g) 
was preserved at 25°C. For water bottle cooling, 2 commercially available water bottles 
(Boots, Nottingham, UK: efficient cooling surface ~22 × 30 cm per each, See Fig. 5.1 
(B)) were filled with 1 litter each of tepid tap water adjusted to 25°C just before the 
application (total-weight 2800 g). Temperatures of the thermal conductor, PCM in the 
superficial layer, and the water bottle were monitored using thermistor probes 
(ThermoTrace, Dräger, Lübeck, Germany) placed on the upper surface of the subject 
covered with a small urethane insulator (1.4 cm diameter, 4 mm thick). 
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Figure 5.1: Diagrams demonstrating the construction and the position of the 
piglet on the PCM cooling mattress and the water bottles 
(A) PCM cooling mattress 
 
PCM mattress:  
16 PCM packs with 
a specific melting 
point of 32°C were 
built into 2 layers 
of 4 × 2 PCM 
sheets.  
 
 
The upper surface of the PCM mattress was covered by a plastic water bag to improve 
thermal conductance. 
Abbreviation: PCM, phase changing material. 
 
(B) Water bottles 
 
Commercial water 
bottles:  
2 water bottles 
were filled with 1 
litter each of tepid 
water at 25°C. 
 
 
These cooling devices were placed underneath the piglet’s head, trunk and limbs. An 
insulator mattress was used underneath the cooling devices so as to allow the heat 
exchange only with the ambient air (25°C) but not with the incubator surface. 
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5.1.6 Temperature control 
Physiological data were recorded every 15 min. Two h following transient 
hypoxia-ischaemia and resuscitation, the piglet was placed on either the PCM mattress 
or the water bottles. We aimed to maintain Trectal within the target range of 33-34°C 
during 2-26 h following resuscitation. To minimise transient overcooling, which was 
commonly observed in our pilot studies (Fig. 5.2), a cotton blanket was applied once 
Trectal was recognised to be at or below 34°C with the regular (every 15 min) data 
recording. The Trectal undershoot was adjusted using cotton blankets thereafter, however 
no more than one blanket was applied (or removed) every 15 min. If Trectal deviated over 
this range, the cooling device was replaced. Twenty-six h after resuscitation, rewarming 
at ~0.5°C/h was commenced by reducing the exposed surface area of the piglet’s skin 
to the cooling device. Intravenous phenobarbital was used when seizures were clinically 
detected. After rewarming to normothermia, the animal was humanely sacrificed 
(intravenous pentobarbitone overdose). 
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Figure 5.2: Pilot study showing transient temperature undershoot after the 
initiation of PCM mattress without blankets 
 
When the PCM mattress was applied to a piglet without using blankets, the animal’s Trectal 
transiently dropped to 32.6°C; this was followed by a gradual recovery and establishment 
of a temperature equilibrium within the target Trectal of 33-34°C at ~7 h after cooling 
initiation. In the main study, because we anticipated a similar period of excessive cooling, 
blankets were applied when the Trectal reached the target range following the initiation of 
cooling. 
Abbreviations: PCM, phase changing material. Trectal, rectal temperature. 
 
 
5.1.7 Data analysis 
The results were compared using ANOVA or Fisher’s exact test when appropriate. 
Results were adjusted for multiple comparisons using Bonferroni correction. For the 
comparison of the temperature stability within the target range, logistic regression with a 
generalised estimating equation was used, taking into account repeated 
measurements. 
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5.2 Results 
Values are shown as mean (SD) unless described. 
 
5.2.1 Summary 
In this chapter, findings in temporal changes for Trectal and its stability provided by 
low-tech cooling devices are presented with information in the clinical procedure 
required during cooling. Although the water bottles and the PCM mattress were both 
able to induce and maintain therapeutic hypothermia between 2-26 h after 
hypoxia-ischaemia, PCM cooling led to a longer period within target Trectal and more 
stable cooling; water bottle cooling required frequent device renewal. 
 
5.2.2 Physiological statement 
One piglet cooled with PCM died 16 h after resuscitation due to respiratory failure. The 
data from this piglet were not used in the comparison during the maintenance phase 
and rewarming. All other piglets survived to the completion of rewarming. Physiological 
data before (6 PCM and 5 water bottles), during (6 PCM and 5 water bottles) and after 
(5 PCM and 5 water bottles) hypoxia-ischaemia were not significantly different between 
groups (Table 5.1). The number of animals developing seizures and requiring 
phenobarbital injection (3/6 for PCM and 2/5 for water bottles) were also similar 
between groups. 
123 
 
Table 5.1: Physiological variables 
  Baseline* Nadir of HI* 2 h* 14 h** 26 h** 
End of 
experiment** 
        
HR (min-1) PCM 165 (29) 208 (24) 160 (16) 121 (18) 117 (29) 170  (8) 
 WB 156 (19) 224 (23) 168 (31) 128 (22) 129 (18) 171 (20) 
        
MABP (mmHg) PCM 51.4 (15.5) 46.6 (20.0) 42.2 (5.1) 36.0 (4.5) 40.0 (5.8) 42.3 (7.9) 
 WB 41.6 (5.9) 37.4 (9.6) 40.4 (4.3) 36.4 (4.7) 45.4 (6.8) 47.2 (9.9) 
        
Arterial blood gas analysis      
pH PCM 7.47 (0.06) 7.47 (0.08) 7.55 (0.11) 7.49 (0.09) 7.53 (0.07) 7.44 (0.10) 
 WB 7.39 (0.05) 7.37 (0.08) 7.43 (0.06) 7.40 (0.13) 7.37 (0.17) 7.36 (0.10) 
        
PaCO2 (kPa) PCM 5.46 (0.96) 5.04 (0.82) 4.39 (1.05) 5.13 (1.22) 4.09 (0.67) 5.83 (1.49) 
 WB 6.62 (0.92) 6.13 (1.56) 5.45 (0.49) 6.65 (1.51) 6.92 (1.67) 6.99 (0.76) 
        
PaO2 (kPa) PCM 11.20 (6.70) 2.61 (0.73) 11.68 (5.34) 9.20 (5.22) 8.22 (5.94) 10.42 (3.53) 
 WB 12.24 (1.50) 3.08 (0.86) 12.10 (1.58) 12.26 (4.88) 13.85 (2.49) 11.67 (5.29) 
        
BE (mmol/L) PCM 5.3 (2.7) 3.6 (3.0) 5.9 (2.8) 5.6 (2.7) 2.8 (1.8) 4.6 (1.8) 
 WB 4.4 (6.5) 0.7 (5.9) 2.9 (5.9) 5.7 (6.8) 3.8 (7.1) 3.0 (6.7) 
        
Lactate  PCM 2.67 (1.71) 3.68 (1.60) 2.17 (1.01) 1.35 (0.64) 1.46 (0.61) 1.21 (0.43) 
(mmol/L) WB 2.66 (0.84) 6.45 (1.71) 2.44 (1.64) 0.97 (0.32) 1.04 (0.33) 1.23 (0.12) 
        
Data shown as mean (standard deviation) 
Number of subjects included: * 6 PCM and 5 WB. ** 5 PCM and 5 WB. 
Abbreviations: HR, heart rate. MABP, mean arterial blood pressure. BE, base excess. PCM, 
phase changing material. WB, water bottle. HI, hypoxia-ischaemia.  
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5.2.3 Hypoxic-ischaemic insult and aEEG change with time 
 (6 PCM and 5 water bottles) 
At the end of the insult the mean upper (and lower) margins of aEEG in PCM and water 
bottle groups were 38.4 (36.7) % and 28.6 (33.4) % of baseline; this gradually increased 
to 65.7 (42.7) % and 53.1 (51.8) % toward the end of the experiment (See Table 5.2). 
There was no intergroup difference in the aEEG margins throughout experiment. At the 
insult nadir (lower margin) and experiment end (upper margin), only water bottle cooled 
piglets had smaller aEEG margins compared with baseline (both p < 0.05). 
 
Table 5.2: Electro-cortical activity with time 
 
 
Baseline End of HI 2 h 14 h 26 h 
End of 
experiment 
  PCM  
upper 22.5 (7.9) 
10.2 (4.1) 
6.8 (6.6) 
3.5 (3.6) 
10.8 (10.0) 
5.8 (4.5) 
13.2 (9.0) 
5.5 (2.8) 
12.2 (7.9) 
5.3 (2.8) 
10.7 (5.9) 
6.1 (2.5) lower 
  WB  
upper 26.1 (1.9) 
12.8 (1.2) 
7.5 (8.7) 
4.5* (3.7) 
12.8 (12.9) 
6.1 (6.3) 
11.5 (8.2) 
5.2 (3.5) 
11.9 (7.4) 
5.3 (3.3) 
13.9* (4.1) 
6.5 (2.2) lower 
Data shown as mean (standard deviation) 
*p < 0.05, comparison vs. baseline, ANOVA with Bonferroni correction  
Abbreviations: PCM, phase changing material. WB, water bottle. HI, hypoxia-ischaemia. 
 
5.2.4 Initiation of cooling 
 (6 PCM and 5 water bottles unless otherwise stated) 
PCM cooled piglets achieved Trectal 33-34°C at 1.9 (0.3) h after placing on the PCM 
mattress; water bottle cooled animals took 1.8 (0.5) h (this excluded one outlier which 
required water bottle replacement before reaching target range at 11.8 h (Table 5.3)). 
The Trectal fell transiently below 33°C in 4 piglets, 2 from the PCM group (for 0.5 and 2.0 
h) and 2 from the water bottle group (for 1.3 and 3.0 h), which resolved when the 
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temperatures of the PCM mattress and water bottles rose above 30°C following the 
application of blankets. 
 
Table 5.3: Cooling profile with PCM and water bottles 
  PCM  WB  p value 
  Induction phase  n = 6 n = 5  
     Time to reach 34°C  (h)  1.9 (0.3)  3.8 (4.5)  NS  
  Maintenance phase  n = 5 n = 5  
     Trectal  (°C)  33.4 (0.2)  33.9 (0.5) NS  
     Time within 33-34°C  (h)  18.45 (2.06)  11.80 (5.23)  < 0.05 * 
  Requirements for Manipulation  n = 5 n = 5  
     Average blanket number  1.5 (0.8)  0.6 (0.7)  NS  
     Change in blanket number  10.4 (4.0)  11.6 (8.6)  NS  
     Cooling device replaced  0 (0) 1.2 (1.1)  < 0.05 ¶  
Data shown as mean (standard deviation) 
* ANOVA ¶ Fisher’s exact test 
Abbreviations: PCM, phase changing material. WB, water bottle. NS, not significant. 
 
 
5.2.5 Maintenance of cooling 
 (5 PCM and 5 water bottles) 
Once the Trectal target was achieved, there was a gradual increase in PCM temperature, 
which plateaued at around its melting point (Fig. 5.3 (A)). In PCM cooled piglets there 
was no requirement for PCM mattress renewal (Table 5.3). In the water bottle group, 
there was also a gradual increase in water bottle temperature which caused the gradual 
increase in Trectal (Fig. 5.3 (B)). Four out of 5 water bottle cooled piglets required renewal 
of water bottles at 12.2 (4.4) h after induction of cooling (Table 5.3). The need for 
cooling device renewal differed between PCM and water bottle groups (p < 0.05). 
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During the cooling period the PCM group remained within the target Trectal range for 
longer compared to the water bottle group (p < 0.01 when observations within the target 
range were compared and p < 0.05 when incorporating the correlation among repeated 
observations); there was no difference in the number of blankets applied and the 
number of blanket manipulations. 
 
5.2.6 Rewarming 
 (5 PCM and 5 water bottles) 
Gradual rewarming was achieved by reducing the exposed surface area of the piglet 
skin to the PCM mattress and water bottles. No adverse effects were apparent at the 
completion of rewarming (Fig. 5.3). 
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Figure 5.3: Changes in rectal and cooling device temperatures with time in a 
representative piglet from the group cooled with PCM and water 
bottles 
(A) PCM 
 
 
 
 
 
 
 
(B) Water bottles 
 
 
 
 
 
 
 
 
The target Trectal between 33-34°C was achieved ~2 h after the induction with PCM 
mattress and water bottles. In the piglet cooled with the PCM mattress, the device 
temperature remained at its melting point throughout the cooling period, leading to a 
more stable Trectal (A). In the animal cooled with water bottles, there was a gradual 
increase in the Trectal in parallel with the increase in the water bottle temperature; a new 
set of water bottles were required at 16 h after cooling initiation (B).  
Both cooling devices required blankets to avoid excessive cooling (the use of blankets is 
shown as grey bars in the figures). Gradual rewarming was achieved by reducing the 
exposed surface area of the piglet skin to the PCM mattress and the water bottles. 
Abbreviations: Trectal, rectal temperature. PCM, phase changing material. WB, water bottle. 
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5.3 Brief Discussion  
5.3.1 Summary 
The current study confirmed the hypothesis that simple, low-tech cooling devices can 
induce and maintain therapeutic hypothermia effectively in a porcine model of neonatal 
encephalopathy. However, even with continuous monitoring of Trectal, water bottle 
cooling resulted in considerable temperature drifts compared to PCM cooling. PCM 
mattress, with its heat-buffering function, appeared to be more suitable for the induction 
and maintenance of cooling before admission to tertiary cooling centres. The findings of 
this study are discussed in this chapter. 
 
- Key Findings from this Study 
This study demonstrates that simple, low-tech cooling devices, such as water bottles 
filled with tepid water at 25oC and a PCM mattress with a melting point of 32oC, were 
able to induce and maintain therapeutic hypothermia effectively in a porcine model of 
neonatal encephalopathy for at least 24 h. PCM cooling led to a longer period within 
target Trectal and more stable cooling compared to water bottle cooling. However, both 
approaches required frequent fine tuning by adjusting the number of blankets insulating 
the piglet to maintain stable temperatures. Although PCM appeared to induce more 
stable cooling than water bottles, it is unknown whether it would remain effective for the 
72 h recommended for therapeutic hypothermia and whether its composition may need 
modification for optimal treatment of human infants. Such clinical validation is urgently 
needed. 
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- What is already known and what our study adds 
What is already known: 
 Mild to moderate therapeutic hypothermia following perinatal hypoxia-ischaemia 
can reduce mortality and the incidence of moderate to severe neurological deficit at 
18 months in an intensive care setting.  
 This therapy does not yet reach low- and mid-resource settings where the incidence 
of neonatal encephalopathy is more common; the development and validation of 
effective, safe, low-maintenance and low-cost cooling methods is urgently required 
in the context of carefully conducted randomised controlled trials of cooling. 
 
What this study adds: 
 Two low-cost, low-tech cooling devices (water bottles and a mattress made from 
PCM with a melting point of 32oC) can induce and maintain mild to moderate 
hypothermia in a piglet model.  
 Compared with water bottles, the PCM mattress provided more stable hypothermia 
without the need for device renewal for up to 24 h. 
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5.3.2 Induction and maintenance of hypothermia 
With the exception of one animal in the water bottle group, hypothermia was induced 
within ~2 h with both cooling mattresses. Although this may appear to be slower than 
some clinical studies (8, 9, 145, 146), this does not account for the higher normal 
temperature for the piglet (38.5-39.0oC) than the human infant (~37oC); more rapid 
induction of cooling may be possible using pre-cooled or additional coolants. However 
our recent clinical study has highlighted that, even in equatorial Africa, many high risk 
infants in low-resource settings are hypothermic on admission to the baby unit (147) 
and so may require maintenance of, rather than induction of, hypothermia.  
 
In human infants non-shivering thermogenesis contributes to maintain the body 
temperature utilising the relatively large stores of brown adipose tissue under the 
regulation of the sympathetic nervous system and an uncoupling protein (UCP1) 
(148-150). Caesarean section reduces postnatal non-shivering thermogenesis 
compared with vaginal delivery due to a lower postpartum surge in thyroid hormones 
and reduced sympathoadrenal activity (151, 152),while those born vaginally will activate 
heat production (152). In addition to the delivery mode, perinatal factors such as 
maternal analgesia, perinatal hypoxia-ischaemia, sleep status, seizures, ventilation and 
use of postnatal sedation may all influence the neonatal metabolic rate and heat 
production (153, 154). Fluctuations in Trectal and occasional periods of excessive 
hypothermia have been observed even with high-tech electric cooling devices (6, 146, 
155). Although no significant adverse effects have been seen with mild to moderate 
hypothermia used in the randomised controlled trials of cooling, it is possible that 
deeper hypothermia than that used in the trials may be associated with a higher risk of 
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adverse events, and it would be desirable that such temperature fluctuations are 
minimised. In this study, both low-tech cooling devices induced a Trectal stability 
comparable to that seen in the clinical studies (146). The temperature plateau reached 
by the PCM mattress was more stable and may allow for less frequent temperature 
monitoring compared with water bottles and other cooling devices which do not have a 
temperature buffering effect.  
 
With the PCM mattress any slight overcooling was addressed by adding cotton blankets 
(Fig. 5.3 (A)). A significant undershoot in the Trectal from the target range may, however 
be difficult to manage with blankets alone due to the robust intrinsic heat buffering 
capacity of PCM. The use of PCM mattresses with multiple melting points may facilitate 
precise cooling in infants with differing levels of heat production. 
Several important points were ascertained from a series of pilot studies not described 
here: (i) a polytrianfoam insulator is required underneath the cooling device to minimise 
heat exchange with the incubator surface; (ii) once the target Trectal is attained, transient 
but prompt rewarming is essential to minimise Trectal undershoot (Fig. 5.4); (iii) a larger 
coolant surface area is required for a longer cooling effect; (iv) a heat conductor is 
required between the animal and PCM mattress to prevent a localised phase change; 
(v) 32°C was more suitable than 28°C as the PCM melting point because the latter 
caused a prolonged period of overcooling. Although the current composition and 
amount of PCM was optimised for our experimental setting, further refinements in the 
amount and composition of PCM may be needed to provide optimal therapy for human 
infants. 
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Figure 5.4: Schematic diagram demonstrating the establishment of a 
temperature equilibrium following the induction of cooling 
with PCM 
 
(a) Temperature equilibrium before the initiation of cooling: the animal’s thermogenesis 
equilibrates with the heat release to the ambience. (b) Rapid induction of hypothermia 
with the PCM: the PCM mattress rapidly deprives heat from the animal due to a large 
temperature difference between the animal and the mattress, and also to the superior 
thermal conductance of the device compared with the ambient air. The heat buffering 
effect of PCM is not expected until the temperature of PCM reaches its melting 
temperature. (c) Target temperature without equilibrium: Although the target Trectal is 
achieved, the PCM temperature still remains cooler than its melting point, and the 
animal’s heat loss remains greater than its thermogenesis, leading to (d) transient 
excessive cooling. After the PCM temperature reaches its melting point, there remains 
only small heat exchange between the animal and PCM due to only small temperature 
difference between each other. This results in the equilibrium of heat exchange within 
target Trectal (e). 
Abbreviation: PCM, phase changing material. 
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5.3.3 Limitations of the study 
The duration of cooling was shorter compared with clinical studies due to ethical and 
practical reasons. Our study was not designed to incorporate the variations in 
endogenous thermogenesis and environmental temperatures. A different ambient 
temperature, especially with diurnal temperature swing, may also affect the efficacy, 
stability and the life of coolant. Hypoxic-ischaemic insult given to the animal may be 
different from clinical perinatal asphyxia, as we used carotid occlusion simultaneously 
with systemic hypoxia. Indeed, there was only little change in arterial blood pH even at 
the nadir of the insult. However, the combination of these procedures is known to result 
in histopathological brain injury similar to human newborn infants following moderate to 
severe perinatal asphyxia (62, 156). In addition, the newborn piglet is smaller in size, 
has more mature skin, has a higher normal core temperature, and is more dependent 
on shivering thermogenesis compared with the human infant (150). These differences 
have to be carefully considered when interpreting the findings, and the effective cooling 
duration of the PCM-32oC mattress and optimal melting point for newborn infants need 
to be addressed. 
 
5.3.4 Clinical Implications 
Therapeutic hypothermia is a safe and promising treatment for birth asphyxia in the 
developed world. As many infants are born outside the regional perinatal centre, cooling 
during transport has become an increasingly common practice (6), because there is a 
consensus that, cooling should be started within 6 h of birth to be effective (13). Safe 
cooling methods and close monitoring of core temperature are vitally important during 
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transport; we suggest that water bottles at 25oC or PCM mattress (32oC) may be 
effective for transportation or early MRI.  
The standardisation of such effective, safe, low-maintenance and low-cost cooling 
methods is urgently required for the possible benefit of therapeutic hypothermia to reach 
the areas of the world that have the highest prevalence of neonatal encephalopathy and 
its sequelae (13). We have shown that both water bottles and a mattress made from 
PCM-32oC may substitute for expensive cooling devices in a low-resource setting 
although continuous temperature monitoring and frequent modification of the insulation 
are essential. These low-tech devices are re-usable and much cheaper than the more 
sophisticated electronic devices used in the developed countries. Although the PCM 
mattress is currently more expensive (~£300-500 per mattress) compared with water 
bottles (~£10), the cost is likely to reduce significantly with expanded production. 
Therapeutic hypothermia with water bottles (water temperature 25oC) and PCM has 
been successfully achieved in pilot cooling studies in equatorial Africa and sowth-west 
India respectively, settings with minimal diurnal and seasonal swings in temperature 
(147, 157). 
 
5.3.5 Conclusion 
Therapeutic hypothermia can be induced and maintained using low-tech devices such 
as water bottles and a PCM mattress in a porcine model of neonatal encephalopathy. 
Although cooling with the PCM mattress provided more stable cooling compared with 
water bottles, further refinements in the size, composition, insulation and melting point 
of the PCM mattress may be required to optimise effective therapeutic hypothermia for 
the human newborn.  
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Chapter 6 
Overall conclusion and implication of the findings from this thesis  
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6.1 Conclusion 
Under whole body cooling, selective head cooling, and even normothermia, regional 
brain temperatures depend on the body weight of the subject presumably due to the 
difference in the surface to volume ratio of the head, and subsequent alteration in the 
efficacy of heat exchange at the scalp surface. In contrast to the observation in 
anaesthetised piglets, in human healthy newborn infants, brain temperatures were 
associated with cerebral perfusion and ambient temperature, but not with the body 
weight and cerebral metabolism. Cerebral perfusion showed closest positive 
association with superficial brain temperatures, suggesting the heat delivery to the 
superficial brain via blood flow. Temperature values and supportive treatments, which 
provide the optimal neuroprotective property to different brain regions, have to be 
investigated. Further identification of regulating factors for the regional brain 
temperature may help establish a cooling method to accomplish the precise 
temperature control within a given cerebral region.  
Low-tech, low-cost heat buffering mattress made of PCMs provided more stable 
temperature control compared to non-heat-buffering water bottles, which may help 
facilitate safe cooling in low resource settings and cooling during transfer to tertiary 
centres when used with continuous body temperature monitoring. The relevance and 
utility of cotside monitoring techniques for cerebral perfusion and metabolism, and PCM 
cooling also need to be confirmed in the clinical cases.  
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6.2 Determinants of regional cerebral temperatures: variables recognised 
in this current thesis and other potential variables 
In an anaesthetised newborn piglet model, where the cardio-pulmonary function is 
stably controlled, and the influence of motion and sympathetic stimulation to heat 
generation is minimised, the body size was the central determination factor of the 
cerebral temperature distribution. The dependence of the brain temperature on the body 
weight was present even at normothermic condition, suggesting that heat dissipation 
from the scalp surface to the cooler ambient air occurred at a greater extent in smaller 
subjects compared to peers. The influence of the body size on the brain temperature 
significantly increased under selective head cooling, where a substantial temperature 
gradient was created between the superficial brain and deep brain. In the clinical study 
which enrolled healthy newborn infants, we were not able to confirm the association 
between regional brain temperatures and the body weight, presumably because of the 
relatively limited variations in the body size and the brain temperature under 
normothermic, thermo neutral condition. Instead, a positive correlation was observed 
between cerebral perfusion and superficial brain temperatures, suggesting that the 
superficial brain may be warmed up by the blood flow, which is distributed to the brain 
surface and then penetrates the parenchyma towards the deep brain structure. Future 
clinical studies are required to obtain the surrogate temperature values for the regional 
brain tissue to distribute the optimal cooling level to the target brain regions. 
 
  
138 
 
6.3 Estimation of regional cerebral temperatures 
Our current study suggested that the zero-heat flux tissue core thermometer can be a 
handy proxy for the cerebral tissue temperature. This technique may be applied under 
both normothermic condition and whole body cooling, where the scale of the 
intracerebral temperature gradient is not outstanding. Taken together with the previous 
reports which investigated the temperature gradient within the brain (55-57, 130, 
158-161), the temperature measures obtained by the probe diameters of 15mm and 
25mm were likely to reflect the temperatures of the cerebral cortex and subcortical white 
matter; for the estimation of the deep brain temperature, probes which can insulate a 
greater surface area would be required. In contrast, under selective head cooling, where 
a substantial temperature gradient is created within the brain tissue, the utility and 
accuracy of the zero-heat flux method has not been fully validated. In addition to the 
nasopharyngeal temperature, which was reported to reflect the deep brain temperature 
even under selective head cooling (57), our current investigation suggested that the 
scalp skin temperature measured using infrared thermometer may predict both the 
superficial and deep brain temperatures. Validation studies for these surrogate 
measures are required using non-invasive techniques such as magnetic resonance 
spectroscopic imaging for the 3-dimensional temperature maps. 
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6.4 Cerebral temperature control based on the understanding of its 
determinants 
Currently in the clinical practice, the level of cooling is adjusted with the core body 
temperature as a proxy of the brain temperature (7-9). However, our current study 
highlighted that the brain temperature can widely vary between cerebral regions as well 
as between subjects, even when the core body temperature was successfully controlled 
to a similar target level. Especially when selective head cooling is used, changes in the 
cap temperature can cause considerable alteration of the temperature distribution to the 
cerebral tissue. Clinical studies have demonstrated that selective head cooling and 
whole body cooling are similarly safe and neuroprotective following perinatal asphyxia 
(47). In the light of this observation, the use of whole body cooling appears to have been 
the first choice in clinical practice (47, 141) because it is practical and simple, and leads 
to a stable core-body temperature. However, given that several clinical factors, which 
influence the beneficial effect of selective head cooling, have already been identified, 
further titration of cooling level according to the body size, encephalopathy grade, CBF, 
cerebral metabolism and other factors may significantly improve outcomes. In the future, 
at least for selective head cooling, protocols may have to be revised either to adjust to 
the reliable surrogate for superficial and deep brain temperatures, or to account for the 
body size and cerebral perfusion in setting the cap temperature e.g. to use relatively 
higher cap temperature for infants with small body size or poor cerebral perfusion to 
avoid excessive cooling in the superficial structure. Further understanding of regulatory 
factors of regional brain temperatures may help deliver a tailored cooling level to a given 
brain region, which may provide optimal protection at the site. The use of non-invasive 
cotside monitoring techniques of CBF and brain metabolism, like ours, may accelerate 
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the accumulation of clinical evidence required to refine neuroprotective treatments 
although the accuracy of monitoring needs to be validated and improved. 
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6.5 Low-tech device to provide safe and stable pre-hospital cooling 
Following hypoxia-ischaemia, despite resuscitation and apparent restoration of normal 
energy metabolism (the latent phase), neurotoxic cascades are activated (162, 163). 
Both experimental and clinical evidence suggests that neuroprotective treatments 
should be commenced as early as possible, because the beneficial effect of 
neuroprotective treatments are less effective with increasing time from the injury 
especially following most severe hypoxia-ischaemia (20, 164-166). Currently in clinical 
practice, despite the best attempts of clinicians, a considerable number of 
encephalopathic newborn infants arrive at tertiary cooling centres close to or after 6 h of 
birth (the end of the apparent therapeutic window) (8, 9, 141, 166). The feasibility of 
initiating cooling during transport and before admission to tertiary centres has been 
investigated (89, 167-170). In some of the early studies, where non-servo-controlled 
cooling methods such as ice packs, fans or passive cooling were used without routine 
monitoring of core-body temperature, up to 34% of infants were cooled below the target 
temperature range. This emphasises the importance of continuous core temperature 
monitoring. In our study, even with the continuous Trectal monitoring, cooling induced by 
water bottles resulted in substantial temperature drifts. In contrast, PCM mattress led to 
more stable body temperature profile over a period of several hours; the development of 
techniques which provide stable body temperature control of not only cooling but also 
smoothing the temperature drifts, may be highly beneficial for pre-hospital cooling. 
Although PCMs are much more expensive compared to water bottles, they are 
re-usable and are still much cheaper than electronic devices used in the developed 
countries. Although further studies are needed to assess PCM’s use in tropical setting 
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(i.e. warmer than the melting point of PCM), this cooling modality might be suitable for 
the use in low-resource settings (157).  
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6.6 Future works 
Although our study provided clinically useful feedback in improving the safety and 
efficacy of therapeutic hypothermia in the newborn infant, further clinical studies are 
needed before changing the clinical protocol. To “deliver” the precise temperature 
values to given cerebral regions, more information has to be accumulated to allow the 
estimation of regional brain temperatures using clinical factors such as the cooling 
device temperature, ambient temperature, infant’s body size, cerebral perfusion, level of 
consciousness, and the metabolic state of the brain. Also, optimal temperature values 
for each cerebral region following specific injury type and depth have to be confirmed in 
preclinical and clinical studies using advanced neuroimaging techniques. 
Simultaneously, cotside monitoring system for the regional cerebral temperature should 
be developed and validated, using temperature mapping techniques such as magnetic 
resonance spectroscopic temperature imaging (171). In addition, the establishment of 
non-invasive cotside technique to monitor the cerebral perfusion and metabolism may 
help adjust the level of cardiac support, cap temperature for selective head cooling, and 
sedation during cooling, which should also be addressed in the future experimental and 
clinical studies. Finally, our study suggested the benefit of using heat-buffering mattress 
made of PCMs under low-resource settings such as pre-hospital cooling; clinical studies 
need to confirm the benefit of initiating therapeutic hypothermia before admission with 
combined use of continuous core body temperature monitoring and PCM mattress. 
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6.7 Strength and limitation 
We were able to prepare an ideal translational setting using the preclinical large animal 
model and the medium risk infants who were hospitalised at a tertiary neonatal intensive 
care unit. In the piglet model, comprehensive temperature monitoring was available 
using both indirect and direct brain tissue temperature monitoring. Our setting of the 
clinical study employed a wide range of non-invasive biomarkers to compensate the 
lack of invasive direct monitoring and to allow estimation of the temperature, perfusion 
and metabolism of the brain tissue by combining multiple factors.  
Several major limitations of the current thesis have to be noted. In the first two studies, 
the study subject did not experience hypoxia-ischaemia, which may significantly alter 
the response in metabolism and perfusion to cooling. Subsequently, no infant in the 
clinical cohort was cared under therapeutic hypothermia. This resulted in a dataset of 
temperatures and other physiological variables within limited ranges of variations, 
leading to the difficulty in identifying important associations between variables. 
Comprehensive data acquisition using a similar protocol to our clinical study is required 
in the future clinical study of therapeutic hypothermia in asphyxiated newborn infants.  
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6.8 Implication of the findings from this thesis 
Spatial temperature distributions within the brain is various, with complex associations 
with clinical factors such as the body size, cerebral perfusion and oxygen metabolism.  
Therapeutic hypothermia, especially when selective head cooling is used, may have to 
account for the body size to deliver consistent cooling levels to the brain tissue. 
Accounting for several central factors such as body weight and cerebral perfusion may 
significantly improve the precision of the temperature delivery to the regional brain 
tissue. Heat-buffering mattress made of PCMs may promote very early induction of 
therapeutic hypothermia before admission with minimum increase in the risk for 
excessive cooling. PCM mattresses may also be of use in low resource settings but this 
still needs to be assessed in the clinical studies. 
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